| Ident. | Authors (with country if any) | Title |
|---|
| 000002 |
Magda Osman [Royaume-Uni] ; Agata Rytersk [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; LINGLING TU [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] | The effects of dopaminergic medication on dynamic decision making in Parkinson's disease |
| 000006 |
Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] | Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients |
| 000008 |
Kay Teschke [Canada] ; Stephen A. Marion [Canada] ; Joseph K. C. Tsui [Canada] ; HUI SHEN [Canada] ; Kathrine Rugbjerg [Canada, Danemark] ; M. Anne Harris [Canada] | Parkinson's Disease and Occupation: Differences in Associations by Case Identification Method Suggest Referral Bias |
| 000009 |
Nir Lipsman [Canada] ; Takashi Nakao [Japon] ; Noriaki Kanayama [Japon] ; Joachim K. Krauss [Allemagne] ; Adam Anderson [Canada] ; Peter Giacobbe [Canada] ; Clement Hamani [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrousky [Canada] ; Thilo Womelsdorf [Canada] ; Andres M. Lozano [Canada] ; Georg Northoff [Canada, Taïwan, République populaire de Chine] | Neural overlap between resting state and self-relevant activity in human subcallosal cingulate cortex - Single unit recording in an intracranial study |
| 000013 |
Frederico Pieruccini-Faria [Canada] ; Jeffery A. Jones [Canada] ; Quincy J. Almeida [Canada] | Motor planning in Parkinson's disease patients experiencing freezing of gait: The influence of cognitive load when approaching obstacles |
| 000015 |
Alexandru Hanganu [Canada] ; Christophe Bedetti [Canada] ; Clotilde Degroot [Canada] ; Beatriz Mejia-Constain [Canada] ; Anne-Louise Lafontaine [Canada] ; Valerie Soland [Canada] ; Sylvain Chouinard [Canada] ; Marie-Andrée Bruneau [Canada] ; Samira Mellah [Canada] ; Sylvie Belleville [Canada] ; Oury Monchi [Canada] | Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally |
| 000016 |
Kenneth Marek [États-Unis] ; John Seibyl [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] ; Chris Hyson [Canada] ; Danna Jennings [États-Unis] | Longitudinal follow-up of SWEDD subjects in the PRECEPT Study |
| 000018 |
YIMING XIAO [Canada] ; Pierre Jannin [France] ; Tiziano D'Albis [France] ; Nicolas Guizard [Canada] ; Claire Haegelen [France] ; Florent Lalys [France] ; Marc Verin [France] ; D. Louis Collins [Canada] | Investigation of Morphometric Variability of Subthalamic Nucleus, Red Nucleus, and Substantia Nigra in Advanced Parkinson's Disease Patients Using Automatic Segmentation and PCA-Based Analysis |
| 000022 |
Sarah Koch [Allemagne, Canada] ; Michael Cassel [Allemagne] ; Karsten Linne [Allemagne] ; Frank Mayer [Allemagne] ; Jürgen Scharhag [Allemagne] | ECG and echocardiographic findings in 10-15-year-old elite athletes |
| 000033 |
Mauro Pettorruso [Italie] ; Giovanni Martinotti [Italie] ; Alfonso Fasano [Canada] ; Giovanna Loria [Italie] ; Marco Di Nicola [Italie] ; Luisa De Risio [Italie] ; Lucia Ricciardi [Italie] ; Gianluigi Conte [Italie] ; Luigi Janiri [Italie] ; Anna Rita Bentivoglio [Italie] | Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study |
| 000039 |
Anthony N. Carlsen [Canada] ; Quincy J. Almeida [Canada] ; Ian M. Franks [Canada] | Using a startling acoustic stimulus to investigate underlying mechanisms of bradykinesia in Parkinson's disease |
| 000047 |
Esther Florin [Allemagne, Canada] ; Désirée Müller [Allemagne] ; Johannes Pfeifer [Allemagne] ; Michael T. Barbe [Allemagne] ; Gereon R. Fink [Allemagne] ; Lars Timmermann [Allemagne] | Subthalamic stimulation modulates self-estimation of patients with Parkinson's disease and induces risk-seeking behaviour |
| 000050 |
Mahan Alavi [Canada] ; Jonathan O. Dostrovsky [Canada] ; Mojgan Hodaie [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada] | Spatial extent of beta oscillatory activity in and between the subthalamic nucleus and substantia nigra pars reticulata of Parkinson's disease patients |
| 000051 |
Patrick S. R. Davidson [Canada] ; Shaun P. Cook [États-Unis] ; Leslie Mcghan [Canada] ; Thomas Bouchard [Canada] ; Richard Camicioli [Canada] | Source memory in normal aging and Parkinson's disease |
| 000054 |
Raymond T. Bartus [États-Unis] ; Tiffany L. Baumann [États-Unis] ; Joao Siffert [États-Unis] ; Christopher D. Herzog [États-Unis] ; Ron Alterman [États-Unis] ; Nicholas Boulis [États-Unis] ; Dennis A. Turner [États-Unis] ; Mark Stacy [États-Unis] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; C. Warren Olanow [États-Unis] | Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients |
| 000055 |
D. Lee [États-Unis] ; D. Y. Henriques [Canada] ; J. Snider [États-Unis] ; D. Song [États-Unis] ; H. Poizner [États-Unis] | REACHING TO PROPRIOCEPTIVELY DEFINED TARGETS IN PARKINSON'S DISEASE: EFFECTS OF DEEP BRAIN STIMULATION THERAPY |
| 000057 |
Holly A. Clayton [Canada] ; Erin K. Cressman [Canada] ; Denise Y. P. Henriques [Canada] | Proprioceptive sensitivity in Ehlers-Danlos syndrome patients |
| 000058 |
Shauna Brady [Canada] ; Paul Lalli [Canada] ; Nisha Midha [Canada] ; Ayechen Chan [Canada] ; Alexandra Garven [Canada] ; Cynthia Chan [Canada] ; Cory Toth [Canada] | Presence of Neuropathic Pain May Explain Poor Performances on Olfactory Testing in Diabetes Mellitus Patients |
| 000060 |
Abdul Qayyum Rana [Canada] ; Ishraq Siddiqui [Canada] ; Masood Zangeneh [Canada] ; Abdul Fattah [Canada] ; Naeem Awan [Canada] ; Muhammad Saad Yousuf [Canada] | Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients |
| 000064 |
Brit Mollenhauer [Allemagne] ; Ellen Trautmann [Allemagne] ; Friederike Sixel-Döring [Allemagne] ; Tamara Wicke [Allemagne] ; Jens Ebentheuer [Allemagne] ; Martina Schaumburg [Allemagne] ; Elisabeth Lang [Allemagne] ; Niels K. Focke [Allemagne] ; Kishore R. Kumar [Allemagne] ; Katja Lohmann [Allemagne] ; Christine Klein [Allemagne] ; Michael G. Schlossmacher [Canada] ; Ralf Kohnen [Allemagne] ; Tim Friede [Allemagne] ; Claudia Trenkwalder [Allemagne] | Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort |
| 000066 |
Leigh Christopher [Canada] ; Antonio P. Strafella [Canada] | Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease |
| 000067 |
M. Lee [Canada] ; E. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | NEUROTOXINS RELEASED FROM INTERFERON-GAMMA-STIMULATED HUMAN ASTROCYTES |
| 000069 |
Nathan Herrmann [Canada] ; Connie Marras [Canada] ; Hadas D. Fischer [Canada] ; XUESONG WANG [Canada] ; Geoff M. Anderson [Canada] ; Paula A. Rochon [Canada] | Management of Neuropsychiatric Symptoms in Long-Term Care Residents with Parkinson's Disease: A Retrospective Cohort Study |
| 000070 |
E. Florin [Allemagne, Canada] ; H. S. Dafsari [Allemagne] ; C. Reck [Allemagne] ; M. T. Barbe [Allemagne] ; K. A. M. Pauls [Allemagne] ; M. Maarouf [Allemagne] ; V. Sturm [Allemagne] ; G. R. Fink [Allemagne] ; L. Timmermann [Allemagne] | MODULATION OF LOCAL FIELD POTENTIAL POWER OF THE SUBTHALAMIC NUCLEUS DURING ISOMETRIC FORCE GENERATION IN PATIENTS WITH PARKINSON'S DISEASE |
| 000074 |
David Mongeon [Canada] ; Pierre Blanchet [Canada] ; Julie Messier [Canada] | Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations |
| 000076 |
M. Anne Harris [Canada] ; HUI SHEN [Canada] ; Stephen A. Marion [Canada] ; Joseph K. C. Tsui [Canada] ; Kay Teschke [Canada] | Head injuries and Parkinson's disease in a case-control study |
| 000078 |
Ned Jenkinson [Royaume-Uni] ; Andrea A. Kühn [Allemagne] ; Peter Brown [Royaume-Uni] | Gamma oscillations in the human basal ganglia |
| 000085 |
Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada] | Dopaminergic contributions to distance estimation in Parkinson's disease: A sensory-perceptual deficit? |
| 000087 |
Jolyn N. A. D'Andrea [Canada] ; Angela M. Haffenden [Canada] ; Sarah Furtado [Canada] ; Oksana Suchowersky [Canada] ; Bradley G. Goodyear [Canada] | Degradation of stored movement representations in the parkinsonian brain and the impact of levodopa |
| 000089 |
Madeleine E. Sharp [Canada] ; Jayalakshmi Viswanathan [Canada] ; Martin J. Mckeown [Canada] ; Silke Appel-Cresswell [Canada] ; A. Jon Stoessl [Canada] ; Jason J. S. Barton [Canada] | Decisions under risk in Parkinson's disease: Preserved evaluation of probability and magnitude |
| 000090 |
E. Florin [Allemagne, Canada] ; R. Erasmi [Allemagne] ; C. Reck [Allemagne] ; M. Maarouf [Allemagne] ; A. Schnitzler [Allemagne] ; G. R. Fink [Allemagne] ; L. Timmermann [Allemagne] | DOES INCREASED GAMMA ACTIVITY IN PATIENTS SUFFERING FROM PARKINSON'S DISEASE COUNTERACT THE MOVEMENT INHIBITING BETA ACTIVITY? |
| 000100 |
Shady Rahayel [Canada] ; Johannes Frasnelli [Canada] | L'odorat dans les maladies d'Alzheimer et de Parkinson : Les cinq sens dessus dessous |
| 000101 |
Dominic Nadeau [Canada] ; Isabelle Giroux [Canada] ; Julie Dufour [Canada] ; Martine Simard [Canada] | Jeu pathologique chez les patients atteints de la maladie de Parkinson |
| 000103 |
Sandra Noble [Canada] ; Abid Ismail [Canada] ; Rafael Godoy [Canada] ; YANWEI XI [Canada] ; Marc Ekker [Canada] | Zebrafish Parla- and Parlb-deficiency affects dopaminergic neuron patterning and embryonic survival |
| 000104 |
WEI SONG [Canada] ; Hillel Zukor [Canada] ; Shih-Hsiung Lin [Canada] ; Adrienne Liberman [Canada] ; Ayda Tavitian [Canada] ; Jeannie Mui [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada] | Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment |
| 000112 |
Wei-Ju Lee [Taïwan] ; Chia-Fen Tsai [Taïwan] ; Serge Gauthier [Canada] ; Shuu-Jiun Wang [Taïwan] ; Jong-Ling Fuh [Taïwan] | The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia |
| 000120 |
Sébastien Helie [États-Unis] ; Erick J. Paul [États-Unis] ; F. Gregory Ashby [États-Unis] | Simulating the effects of dopamine imbalance on cognition: From positive affect to Parkinson's disease |
| 000122 |
Manoj N. Obeyesekere [Canada] ; Peter Leong-Sit [Canada] ; David Massel [Canada] ; Jaimie Manlucu [Canada] ; Simon Modi [Canada] ; Andrew D. Krahn [Canada] ; Allan C. Skanes [Canada] ; Raymond Yee [Canada] ; Lorne J. Gula [Canada] ; George J. Klein [Canada] | Risk of Arrhythmia and Sudden Death in Patients With Asymptomatic Preexcitation: A Meta-Analysis |
| 000129 |
Kaitlyn P. Roland [Canada] ; Jennifer M. Jakobi [Canada] ; Gareth R. Jones [Canada] ; Colin Powell [Canada] | QUALITY OF LIFE AS A DETERMINANT OF FRAILTY PHENOTYPE IN COMMUNITY-DWELLING PERSONS WITH PARKINSON'S DISEASE |
| 000131 |
Anthony N. Carlsen [Canada] ; Dana Maslovat [Canada] ; Ian M. Franks [Canada] | Preparation for voluntary movement in healthy and clinical populations: Evidence from startle : Neurophysiology of the Brainstem |
| 000136 |
Moran Weinberger [Canada] ; William D. Hutchison [Canada] ; Mahan Alavi [Canada] ; Mojgan Hodaie [Canada] ; Andres M. Lozano [Canada] ; Elena Moro [Canada] ; Jonathan O. Dostrovsky [Canada] | Oscillatory activity in the globus pallidus internus: Comparison between Parkinson's disease and dystonia |
| 000148 |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Jenna Sykes [Canada] ; Stephen J. Kish [Canada] | Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs |
| 000150 |
D. Salat-Foix [Canada] ; K. Tran [Canada] ; R. Ranawaya [Canada] ; J. Meddings [Canada] ; O. Suchowersky [Canada] | Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg? |
| 000151 |
Andreas R. Kupsch [Allemagne] ; Nin Bajaj [Royaume-Uni] ; Frederick Weiland [États-Unis] ; Antonio Tartaglione [Italie] ; Susanne Klutmann [Allemagne] ; Melanie Buitendyk [Canada] ; Paul Sherwin [États-Unis] ; Ann Tate [États-Unis] ; Igor D. Grachev [États-Unis] | Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study |
| 000154 |
QIAN XU [Canada, République populaire de Chine] ; HONGLING GUO [Canada] ; XIAOJIE ZHANG [Canada] ; BEISHA TANG [République populaire de Chine] ; FANG CAI [Canada] ; WEIHUI ZHOU [République populaire de Chine] ; WEIHONG SONG [Canada, République populaire de Chine] | Hypoxia regulation of ATP13A2 (PARK9) gene transcription |
| 000155 |
Y. P. Goldberg [Canada] ; S. N. Pimstone [Canada] ; R. Namdari [Canada] ; N. Price [Canada] ; C. Cohen [Canada] ; R. P. Sherrington [Canada] ; M. R. Hayden [Canada] | Human Mendelian pain disorders: a key to discovery and validation of novel analgesics |
| 000161 |
I. Rektorova [République tchèque] ; M. Mikl [République tchèque] ; J. Barrett [Canada] ; R. Marecek [République tchèque] ; I. Rektor [République tchèque] ; T. Paus [Canada] | Functional neuroanatomy of vocalization in patients with Parkinson's disease |
| 000163 |
Jonathan D. S. Sniderman [Royaume-Uni] ; Daniel M. Sado [Royaume-Uni] ; Allan D. Sniderman [Canada] ; William J. Mckenna [Royaume-Uni] | Evaluation of Suspected Right Ventricular Pathology in the Athlete |
| 000168 |
A. Sanchez-Danes [Espagne] ; A. Consiglio [Espagne, Italie] ; Y. Richaud [Espagne] ; I. Rodriguez-Piza [Espagne] ; B. Dehay [Espagne, France] ; M. Edel [Espagne, Australie] ; J. Bove [Espagne] ; M. Memo [Italie] ; M. Vila [Espagne] ; A. Raya [Espagne] ; J. C. Izpisua Belmonte [Espagne, Canada] | Efficient Generation of A9 Midbrain Dopaminergic Neurons by Lentiviral Delivery of LMX1A in Human Embryonic Stem Cells and Induced Pluripotent Stem Cells |
| 000170 |
Orit Zamir [Canada] ; Carolyn Gunraj [Canada] ; ZHEN NI [Canada] ; Filomena Mazzella [Canada] ; Robert Chen [Canada] | Effects of theta burst stimulation on motor cortex excitability in Parkinson's disease |
| 000183 |
Pierre J. Blanchet [Canada] ; Louise Normandeau [Canada] ; Pierre H. Rompre [Canada] | Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: A pilot study |
| 000184 |
Rena K. Mann [Canada] ; Roderick Edwards [Canada] ; JULIE ZHOU [Canada] ; Alison Fenney [Canada] ; Mandar Jog [Canada] ; Christian Duval [Canada] | Comparing movement patterns associated with Huntington's chorea and Parkinson's dyskinesia |
| 000196 |
Ibrahim Mustafa [Canada] ; Ali Elkamel [Canada] ; Ali Lohi [Canada] ; PU CHEN [Canada] ; Said S. E. H. Elnashaie [Malaisie] ; Gamal Ibrahim [Égypte] | Application of continuation method and bifurcation for the acetylcholine neurocycle considering partial dissociation of acetic acid |
| 000202 |
Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; QIN LI [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France] | A Critique of Available Scales and Presentation of the Non-Human Primate Dyskinesia Rating Scale |
| 000204 |
Richard Camicioli [Canada] ; Jennifer Sabino [Canada] ; Myrlene Gee [Canada] ; Thomas Bouchard [Canada] ; Nancy Fisher [Canada] ; Chris Hanstock [Canada] ; Derek Emery [Canada] ; W. R. Wayne Martin [Canada] | Ventricular Dilatation and Brain Atrophy in Patients with Parkinson's Disease with Incipient Dementia |
| 000207 |
Carles Vilarino-Güell [Canada] ; Christian Wider [Suisse] ; Owen A. Ross [États-Unis] ; Justus C. Dachsel [États-Unis] ; Jennifer M. Kachergus [États-Unis] ; Sarah J. Lincoln [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Stephanie A. Cobb [États-Unis] ; Greggory J. Wilhoite [États-Unis] ; Justin A. Bacon [États-Unis] ; Bahareh Behrouz [États-Unis] ; Heather L. Melrose [États-Unis] ; Emna Hentati [États-Unis] ; Andreas Puschmann [États-Unis, Suède] ; Daniel M. Evans [Canada] ; Elizabeth Conibear [Canada] ; Wyeth W. Wasserman [Canada] ; Jan O. Aasly [Norvège] ; Pierre R. Burkhard [Suisse] ; Ruth Djaldetti [Israël] ; Joseph Ghika [Suisse] ; Faycal Hentati [Tunisie] ; Anna Krygowska-Wajs [Pologne] ; Tim Lynch [Irlande (pays)] ; Eldad Melamed [Israël] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Alessandra Solida [Suisse] ; Ruey-Meei Wu [Taïwan] ; Ryan J. Uitti [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; François Vingerhoets [Suisse] ; Matthew J. Farrer [Canada, États-Unis] | VPS35 Mutations in Parkinson Disease |
| 000210 |
Marie-Christine Chartier-Harlin [France] ; Justus C. Dachsel [États-Unis] ; Carles Vilarino-Güell [Canada] ; Sarah J. Lincoln [États-Unis] ; Frédéric Lepretre [France] ; Mary M. Hulihan [États-Unis] ; Jennifer Kachergus [États-Unis] ; Austen J. Milnerwood [Canada] ; Lucia Tapia [Canada] ; Mee-Sook Song [Canada] ; Emilie Le Rhun [France] ; Eugénie Mutez [France] ; Lydie Larvor [France] ; Aurélie Duflot [France] ; Christel Vanbesien-Mailliot [France] ; Alexandre Kreisler [France] ; Owen A. Ross [États-Unis] ; Kenya Nishioka [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Stephanie A. Cobb [États-Unis] ; Heather L. Melrose [États-Unis] ; Bahareh Behrouz [États-Unis] ; Brett H. Keeling [États-Unis] ; Justin A. Bacon [États-Unis] ; Emna Hentati [États-Unis] ; Lindsey Williams [États-Unis] ; Akiko Yanagiya [Canada] ; Nahum Sonenberg [Canada] ; Paul J. Lockhart [Australie] ; Abba C. Zubair [États-Unis] ; Ryan J. Uitti [États-Unis] ; Jan O. Aasly [Norvège] ; Anna Krygowska-Wajs [Pologne] ; Grzegorz Opala [Pologne] ; Zbigniew K. Wszolek [États-Unis] ; Roberta Frigerio ; Demetrius M. Maraganore ; David Gosal ; Tim Lynch ; Michael Hutchinson ; Anna Rita Bentivoglio ; Enza Maria Valente ; William C. Nichols ; Nathan Pankratz ; Tatiana Foroud ; Rachel A. Gibson ; Faycal Hentati ; Dennis W. Dickson [États-Unis] ; Alain Destée [France] ; Matthew J. Farrer [États-Unis, Canada] | Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease |
| 000216 |
James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada] | The Selective Mu-Opioid Receptor Antagonist ADL5510 Reduces Levodopa-Induced Dyskinesia Without Affecting Antiparkinsonian Action in MPTP-Lesioned Macaque Model of Parkinson's Disease |
| 000224 |
Simon Ducharme [Canada, États-Unis] ; Alice W. Flaherty ; Stephen J. Seiner ; Darin D. Dougherty ; Oscar G. Morales | Temporary Interruption of Deep Brain Stimulation for Parkinson's Disease During Outpatient Electroconvulsive Therapy for Major Depression: A Novel Treatment Strategy |
| 000227 |
A. Ashoori [Canada] ; M. J. Mckeown [Canada] ; M. M. K. Oishi [Canada] | Switched manual pursuit tracking to measure motor performance in Parkinson's disease |
| 000228 |
Diego Santos-Garcia [Espagne] ; Mercedes Macias [Espagne] ; Miguel Llaneza [Espagne] ; M Nica Grande [Espagne] ; Raúl De La Fuente-Fernandez [Canada] | Serum Vitamin B12 and Folate Levels in Parkinson's Disease Patients Treated with Duodenal Levodopa Infusion |
| 000231 |
J. H. J. Allum [Suisse] ; K.-S. Tang [Suisse, Pays-Bas] ; M. G. Carpenter [Canada] ; L. B. Oude Nijhuis [Pays-Bas] ; B. R. Bloem [Pays-Bas] | Review of first trial responses in balance control: Influence of vestibular loss and Parkinson's disease |
| 000233 |
Chris S. Hughes [Canada] ; Amelia A. Nuhn [Canada] ; Lynne M. Postovit [Canada] ; Gilles A. Lajoie [Canada] | Proteomics of human embryonic stem cells |
| 000234 |
Marianne Vaugoyeau [France] ; Hussein Hakam [France] ; Jean-Philippe Azulay [France] | Proprioceptive impairment and postural orientation control in Parkinson's disease |
| 000238 |
Meir Plotnik [Israël] ; Nir Giladi [Israël] ; Yaacov Dagan [Israël] ; Jeffery M. Hausdorff [Israël, États-Unis] | Postural instability and fall risk in Parkinson's disease: impaired dual tasking, pacing, and bilateral coordination of gait during the "ON" medication state |
| 000240 |
Kathrine Rugbjerg [Danemark] ; M. Anne Harris [Canada] ; HUI SHEN [Canada] ; Stephen A. Marion [Canada] ; Joseph K. C. Tsui [Canada] ; Kay Teschke [Canada] | Pesticide exposure and risk of Parkinson's disease - a population-based case-control study evaluating the potential for recall bias |
| 000241 |
Roberto Cilia [Canada, Italie] ; SANG SOO CHO [Canada] ; Thilo Van Eimeren [Canada] ; Giorgio Marotta [Italie] ; Chiara Siri [Italie] ; JI HYUN KO [Canada] ; Giovanna Pellecchia [Canada] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] ; Antonio P. Strafella [Canada] | Pathological Gambling in Patients with Parkinson's Disease is Associated with Fronto-Striatal Disconnection: A Path Modeling Analysis |
| 000243 |
T. Tan [Canada] ; Q. J. Almeida [Canada] ; F. Rahimi [Canada] | PROPRIOCEPTIVE DEFICITS IN PARKINSON'S DISEASE PATIENTS WITH FREEZING OF GAIT |
| 000246 |
K. F. Schilter [États-Unis] ; A. Schneider [États-Unis] ; T. Bardakjian [États-Unis] ; J.-F. Soucy [Canada] ; R. C. Tyler [États-Unis] ; L. M. Reis [États-Unis] ; E. V. Semina [États-Unis] | OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype |
| 000249 |
RUITAO WANG [Canada, République populaire de Chine] ; MINGMING ZHANG [Canada] ; WEIHUI ZHOU [Canada] ; Philip T. T. Ly [Canada] ; FANG CAI [Canada] ; WEIHONG SONG [Canada] | NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression |
| 000256 |
Bazoumana Ouattara [Canada] ; Laurent Gregoire [Canada] ; Marc Morissette [Canada] ; Fabrizio Gasparini [Suisse] ; Ivo Vranesic [Suisse] ; Graeme Bilbe [Suisse] ; Donald R. Johns [Suisse] ; Alex Rajput [Canada] ; Oleh. Hornykiewicz [Autriche] ; Ali H. Rajput [Canada] ; Baltazar Gomez-Mancilla [Suisse] ; Therese Di Paolo [Canada] | Metabotropic glutamate receptor type 5 in levodopa-induced motor complications |
| 000261 |
Siddharth Banka [Royaume-Uni] ; Henk J. Blom [Pays-Bas] ; John Walter [Royaume-Uni] ; Majid Aziz [Royaume-Uni] ; Jill Urquhart [Royaume-Uni] ; Christopher M. Clouthier [Canada] ; Gillian I. Rice [Royaume-Uni] ; Arjan P. M. De Brouwer [Pays-Bas] ; Emma Hilton [Royaume-Uni] ; Grace Vassallo [Royaume-Uni] ; Andrew Will [Royaume-Uni] ; Desirée E. C. Smith [Pays-Bas] ; Yvo M. Smulders [Pays-Bas] ; Ron A. Wevers [Pays-Bas] ; Robert Steinfeld [Allemagne] ; Simon Heales [Royaume-Uni] ; Yanick J. Crow [Royaume-Uni] ; Joelle N. Pelletier [Canada] ; Simon Jones [Royaume-Uni] ; William G. Newman [Royaume-Uni] | Identification and Characterization of an Inborn Error of Metabolism Caused by Dihydrofolate Reductase Deficiency |
| 000267 |
Raluca Petrican [Canada] ; Christopher T. Burris [Canada] ; Tania Bielak [Canada] ; Ulrich Schimmack [Canada] ; Morris Moscovitch [Canada] | For My Eyes Only: Gaze Control, Enmeshment, and Relationship Quality |
| 000269 |
Karin Wirdefeldt [Suède, États-Unis] ; Hans-Olov Adami [Suède] ; Philip Cole [États-Unis] ; Dimitrios Trichopoulos [États-Unis] ; Jack Mandel [Canada] | Epidemiology and etiology of Parkinson's disease: a review of the evidence |
| 000274 |
James K. R. Stevenson [Canada] ; Pouria Talebifard [Canada] ; Edna Ty [Canada] ; Meeko M. K. Oishi [Canada, États-Unis] ; Martin J. Mckeown [Canada] | Dyskinetic Parkinson's disease patients demonstrate motor abnormalities off medication |
| 000281 |
Emily Bell [Canada] ; Bruce Maxwell [Canada] ; Mary Pat Mcandrews [Canada] ; Abbas Sadikot [Canada] ; Eric Racine [Canada] | Deep Brain Stimulation and Ethics: Perspectives from a Multisite Qualitative Study of Canadian Neurosurgical Centers |
| 000287 |
Sara Kost [Canada] ; CHAO SUN [Canada] ; WEI XIONG [Canada] ; Kathryn Graham [Canada] ; Carol E. Cass [Canada] ; James D. Young [Canada] ; Benedict C. Albensi [Canada] ; Fiona E. Parkinson [Canada] | Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice |
| 000290 |
Janusz W. Blaszczyk [Pologne] ; Renata Orawiec [Pologne] | Assessment of postural control in patients with Parkinson's disease: Sway ratio analysis |
| 000295 |
Matthias Kliegel [Allemagne] ; Mareike Altgassen [Allemagne] ; Alexandra Hering [Allemagne] ; Nathan S. Rose [Canada] | A process-model based approach to prospective memory impairment in Parkinson's disease |
| 000304 |
Sandra E. Leh [Canada] ; Michael Petrides [Canada] ; Antonio P. Strafella [Canada] | The Neural Circuitry of Executive Functions in Healthy Subjects and Parkinson's Disease |
| 000310 |
I-Jin Yeh [Canada, Taïwan] ; Eric W. Tsang [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada] ; Filomena Mazzella [Canada] ; Yu-Yan Poon [Canada] ; Andres M. Lozano [Canada] ; Robert Chen [Canada] | Somatosensory Evoked Potentials Recorded from the Human Pedunculopontine Nucleus Region |
| 000314 |
Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis] | Reply: Based on the Available Randomized Trial Patients Should Say No to Glutathione for Parkinson's Disease |
| 000318 |
S. W. Hung [Canada, États-Unis] ; G. M. Adeli [Canada] ; T. Arenovich [Canada] ; S. H. Fox [Canada] ; A. E. Lang [Canada] | Patient perception of dyskinesia in Parkinson's disease |
| 000319 |
A. Bharmal [Canada] ; C. Lu [Canada] ; J. Quickfall [Canada] ; D. Crockford [Canada] ; O. Suchowersky [Canada] | Outcomes of Patients with Parkinson Disease and Pathological Gambling |
| 000322 |
Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard [Canada] ; Dominic Langlois [Canada] ; Pierre J. Blanchet [Canada] ; Martin Lemay [Canada] ; Maxime Parent [Canada] | Movement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson's disease |
| 000333 |
Wing-Lok Au [Singapour] ; NI LEI [Canada] ; Meeko M. K. Oishi [Canada] ; Martin J. Mckeown [Canada] | L-Dopa induces under-damped visually guided motor responses in Parkinson's disease |
| 000335 |
E. W. Tsang [Canada] ; C. Hamani [Canada] ; E. Moro [Canada] ; F. Mazzella [Canada] ; Y. Y. Poon [Canada] ; A. M. Lozano [Canada] ; R. Chen [Canada] | Involvement of the human pedunculopontine nucleus region in voluntary movements |
| 000337 |
Estifanos Ghebremedhin [Allemagne, Australie] ; Albert Rosenberger [Allemagne] ; Udo Rüb [Allemagne] ; Mario Vuksic [Croatie] ; Tzeggai Berhe [Canada] ; Heike Bickeböller [Allemagne] ; Rob A. I. De Vos [Pays-Bas] ; Dietmar R. Thal [Allemagne] ; Thomas Deller [Allemagne] | Inverse Relationship Between Cerebrovascular Lesions and Severity of Lewy Body Pathology in Patients With Lewy Body Diseases |
| 000338 |
Rena K. Mann [Canada] ; Roderick Edwards [Canada] ; Julie Zhou [Canada] ; Mandar Jog [Canada] ; Christian Duval [Canada] | Intra- and inter-limb coherency during stance in non-dyskinetic and dyskinetic patients with Parkinson's disease |
| 000342 |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tayyeba Darr [Canada] ; Lili-Naz Hazrati [Canada] ; Naomi P. Visanji [Canada] ; Donna Pires [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations |
| 000343 |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada] | Incidence of Parkinson's Disease Among Hospital Patients with Methamphetamine-Use Disorders |
| 000344 |
Daniel Weintraub [États-Unis] ; Juergen Koester [Allemagne] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Mark Stacy [États-Unis] ; Valerie Voon [Canada] ; Jacqueline Whetteckey [États-Unis] ; Glen R. Wunderlich [Canada] ; Anthony E. Lang [Canada] | Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients |
| 000347 |
Myriam Lafreniere-Roula [Canada] ; Elaine Kim [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Mojgan Hodaie [Canada] ; Jonathan O. Dostrovsky [Canada] | High-frequency microstimulation in human globus pallidus and substantia nigra |
| 000348 |
Angela R. South [Canada] ; Stephanie M. Somers [Canada] ; Mandar S. Jog [Canada] | Gum chewing improves swallow frequency and latency in Parkinson patients: A preliminary study |
| 000355 |
Ian G. M. Cameron [Canada] ; Masayuki Watanabe [Canada] ; Giovanna Pari [Canada] ; Douglas P. Munoz [Canada] | Executive impairment in Parkinson's disease: Response automaticity and task switching |
| 000357 |
Ron Levy [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; Jonathan O. Dostrovsky [Canada] | Event-related desynchronization of motor cortical oscillations in patients with multiple system atrophy |
| 000359 |
Henri Cohen [France, Canada] ; Marie-Hélène Gagne [Canada] ; Ursula Hess [Canada] ; Emmanuelle Pourcher [France, Canada] | Emotion and object processing in Parkinson's disease |
| 000360 |
Sarah C. Lidstone [Canada] ; Michael Schulzer [Canada] ; Katherine Dinelle [Canada] ; Edwin Mak [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; A. Jon Stoessl [Canada] | Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease |
| 000367 |
Melanie Cohn [Canada] ; Morris Moscovitch [Canada] ; Patrick S. R. Davidson [Canada] | Double dissociation between familiarity and recollection in Parkinson's disease as a function of encoding tasks |
| 000370 |
Edeltraut Kröger [Pays-Bas, Canada] ; Rob Van Marum [Pays-Bas] ; Patrick Souverein [Pays-Bas] ; Toine Egberts [Pays-Bas] | Discontinuation of Cholinesterase Inhibitor Treatment and Determinants thereof in the Netherlands: A Retrospective Cohort Study |
| 000378 |
Emmanuelle Pourcher [Canada, France] ; Sophie Remillard [Canada] ; Henri Cohen [Canada, France] | Compulsive habits in restless legs syndrome patients under dopaminergic treatment |
| 000381 |
Jon B. Doan [Canada] ; Ian Q. Whishaw [Canada] ; Sergio M. Pellis [Canada] ; Oksana Suchowersky [Canada] ; Natalie De Bruin [Canada] ; Lesleya. Brown [Canada] | Challenging context affects standing reach kinematics among Parkinson's disease patients |
| 000386 |
Behnam A. Baghbaderani [Canada] ; Karim Mukhida [Canada] ; Arindom Sen [Canada] ; Michael S. Kallos [Canada] ; Murray Hong [Canada] ; Ivar Mendez [Canada] ; Leo A. Behie [Canada] | Bioreactor Expansion of Human Neural Precursor Cells in Serum-Free Media Retains Neurogenic Potential |
| 000390 |
Cathy Lu [Canada] ; Aamir Bharmal [Canada] ; Zelma H. Kiss [Canada] ; Oksana Suchowersky [Canada] ; Angela M. Haffenden [Canada] | Attention and reach-to-grasp movements in Parkinson's disease |
| 000392 |
M. Lafreniere-Roula [Canada] ; O. Darbin [États-Unis] ; W. D. Hutchison [Canada] ; T. Wichmann [États-Unis] ; A. M. Lozano [Canada] ; J. O. Dostrovsky [Canada] | Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients |
| 000393 |
André Bonnici [Canada] ; Carola-Ellen Ruiner [Canada] ; Lyne St-Laurent [Canada] ; David Hornstein [Canada] | An Interaction Between Levodopa and Enteral Nutrition Resulting in Neuroleptic Malignant-Like Syndrome and Prolonged ICU Stay |
| 000401 |
P.-J. Blanchet [Canada] ; B. Lalonde [Canada] ; G.-J. Lavigne [Canada] | Douleur orofaciale et désordres oromoteurs |
| 000411 |
WEI SONG [Canada] ; Amar Patel [Canada] ; Hamid Y. Qureshi [Canada] ; DONG HAN [Canada] ; Hyman M. Schipper [Canada] ; Hemant K. Paudel [Canada] | The Parkinson disease-associated A30P mutation stabilizes α-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells |
| 000420 |
Emily Bell [Canada] ; Ghislaine Mathieu [Canada] ; Eric Racine [Canada] ; Konstantin V. Slavin [États-Unis] | Preparing the ethical future of deep brain stimulation. Commentary |
| 000421 |
P. A. Guertin [Canada] ; C. Brochu [Canada] | Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient |
| 000436 |
Pershia Samadi [Canada] ; Alex Rajput [Canada] ; Frédéric Calon [Canada] ; Laurent Gregoire [Canada] ; Oleh Homykiewicz [Canada, Autriche] ; Ali H. Rajput [Canada] ; Thèrèse Di Paolo [Canada] | Metabotropic Glutamate Receptor II in the Brains of Parkinsonian Patients |
| 000441 |
C. Allyson Jones [Canada] ; Sheri L. Pohar [Canada] ; Scott B. Patten [Canada] | Major depression and health-related quality of life in Parkinson's disease |
| 000446 |
I. A. Prescott [Canada] ; J. O. Dostrovsky [Canada] ; E. Moro [Canada] ; M. Hodaie [Canada] ; A. M. Lozano [Canada] ; W. D. Hutchison [Canada] | Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients |
| 000448 |
Oliver Cooper [États-Unis] ; Arnar Astradsson [États-Unis] ; Penny Hallett [États-Unis] ; Harold Robertson [Canada] ; Ivar Mendez [Canada] ; Ole Isacson [États-Unis] | Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients |
| 000451 |
Sadayuki Hashioka [Canada] ; Andis Klegeris [Canada] ; Claudia Schwab [Canada] ; Patrick L. Mcgeer [Canada] | Interferon-γ-dependent cytotoxic activation of human astrocytes and astrocytoma cells |
| 000452 |
Kaviraja Udupa [Canada] ; ZHEN NI [Canada] ; Carolyn Gunraj [Canada] ; Robert Chen [Canada] | Interactions between short latency afferent inhibition and long interval intracortical inhibition |
| 000454 |
T. D. L. Steeves [Canada] ; J. Miyasaki [Canada] ; M. Zurowski [Canada] ; A. E. Lang [Canada] ; G. Pellecchia [Canada] ; T. Van Eimeren [Canada] ; P. Rusjan [Canada] ; S. Houle [Canada] ; A. P. Strafella [Canada] | Increased striatal dopamine release in Parkinsonian patients with pathological gambling : a [11C] raclopride PET study |
| 000460 |
D. Mongeon [Canada] ; P. Blanchet [Canada] ; J. Messier [Canada] | IMPACT OF PARKINSON'S DISEASE AND DOPAMINERGIC MEDICATION ON PROPRIOCEPTIVE PROCESSING |
| 000461 |
Richard M. Camicioli [Canada] ; Thomas P. Bouchard [Canada] ; Martin J. Somerville [Canada] | Homocysteine Is Not Associated with Global Motor or Cognitive Measures in Nondemented Older Parkinson's Disease Patients |
| 000464 |
Hyman M. Schipper [Canada] ; WEI SONG [Canada] ; Hillel Zukor [Canada] ; Jacob R. Hascalovici [Canada] ; David Zeligman [Canada] | Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement |
| 000465 |
Hillel Zukor [Canada] ; WEI SONG [Canada] ; Adrienne Liberman [Canada] ; JEANNIE MUI [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada] | HO-1-mediated macroautophagy : a mechanism for unregulated iron deposition in aging and degenerating neural tissues |
| 000469 |
Stuart W. S. Macdonald [Canada, Suède] ; Simon Cervenka [Suède] ; Lars Farde [Suède] ; Lars Nyberg [Suède] ; Lars B Ckman [Suède] | Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning |
| 000470 |
Kenneth D. Cronin [États-Unis] ; DONGLIANG GE [États-Unis] ; Paul Manninger [Canada] ; Colton Linnertz [États-Unis] ; Anna Rossoshek [États-Unis] ; Bonnie M. Orrison [États-Unis] ; David J. Bernard [États-Unis] ; Omar M. A. Ei-Agnaf [Émirats arabes unis] ; Michael G. Schlossmacher [Canada] ; Robert L. Nussbaum [États-Unis] ; Ornit Chiba-Falek [États-Unis] | Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain |
| 000477 |
Abdoul Kane [Canada] ; William D. Hutchison [États-Unis, Canada] ; Mojgan Hodaie [États-Unis, Canada] ; Andres M. Lozano [États-Unis, Canada] ; Jonathan O. Dostrovsky [États-Unis, Canada] | Dopamine-dependent high-frequency oscillatory activity in thalamus and subthalamic nucleus of patients with Parkinson's disease |
| 000478 |
Vesna Sossi [Canada] ; Katherine Dinelle [Canada] ; Geoffrey J. Topping [Canada] ; James E. Holden [États-Unis] ; Doris Doudet [Canada] ; Michael Schulzer [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Raul De La Fuente-Femandez [Canada] | Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's : an in vivo imaging study |
| 000485 |
M. Mallar Chakravarty [Canada] ; Abbas F. Sadikot [Canada] ; Jürgen Germany [Canada] ; Pierre Hellier [France] ; Gilles Bertrand [Canada] ; D. Louis Collins [Canada] | Comparison of Piece-Wise Linear, Linear, and Nonlinear Atlas-to-Patient Warping Techniques: Analysis of the Labeling of Subcortical Nuclei for Functional Neurosurgical Applications |
| 000488 |
Benedicte Ballanger [Canada] ; Andres M. Lozano [Canada] ; Elena Moro [Canada] ; Thilo Van Eimeren [Canada] ; Clement Hamani [Canada] ; Robert Chen [Canada] ; Roberto Cilia [Canada] ; Sylvain Houle [Canada] ; YU YAN POON [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada] | Cerebral Blood Flow Changes Induced by Pedunculopontine Nucleus Stimulation in Patients With Advanced Parkinson's Disease: A [15O] H2O PET Study |
| 000490 |
M. Denheyer [Canada] ; Z. H. Kiss [Canada] ; A. M. Haffenden [Canada] | Behavioral effects of subthalamic deep brain stimulation in Parkinson's disease |
| 000495 |
Ana Djarmati [Allemagne] ; Johann Hagenah [Allemagne] ; Kathrin Reetz [Allemagne] ; Susen Winkler [Allemagne] ; Maria Isabel Behrens [Chili] ; Heike Pawlack [Allemagne] ; Katja Lohmann [Allemagne] ; Alfredo Ramirez [Allemagne] ; Vera Tadic [Allemagne] ; Norbert Brüggemann [Allemagne] ; Daniela Berg [Allemagne] ; Hartwig R. Siebner [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; Ferdinand Binkofski [Allemagne] ; Vladimir S. Kostic [Serbie] ; Jens Volkmann [Allemagne] ; Thomas Gasser [Allemagne] ; Christine Klein [Allemagne] | ATP13A2 Variants in Early-Onset Parkinson's Disease Patients and Controls |
| 000502 |
Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Benedicte Ballanger [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Elena Moro [Canada] | rCBF Changes Associated with PPN Stimulation in a Patient with Parkinson's disease : A PET Study |
| 000503 |
Magdalena Szczerbowska-Boruchowska [Pologne] | X-ray fluorescence spectrometry, an analytical tool in neurochemical research |
| 000504 |
Chinar Dara [Canada] ; Laura Monetta [Canada] ; Marc D. Pell [Canada] | Vocal emotion processing in Parkinson's disease : Reduced sensitivity to negative emotions |
| 000508 |
Renato P. Munhoz [Brésil] ; Yosuke Wakutani [Canada] ; Connie Marras [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Lineu C. Werneck [Brésil] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada] | The G2019S LRRK2 Mutation in Brazilian Patients with Parkinson's Disease : Phenotype in Monozygotic Twins |
| 000512 |
Margaret K. Y. Mak [Hong Kong] ; Aftab Patla [Canada] ; Christina Hui-Chan [Hong Kong] | Sudden turn during walking is impaired in people with Parkinson's disease |
| 000517 |
F. Paquet [Canada] ; M. A. Bedard [Canada] ; M. Levesque [Canada] ; P. L. Tremblay [Canada] ; M. Lemay [Canada] ; P. J. Blanchet [Canada] ; P. Scherzer [Canada] ; S. Chouinard [Canada] ; J. Filion [Canada] | Sensorimotor adaptation in Parkinson's disease : evidence for a dopamine dependent remapping disturbance |
| 000525 |
Moran Weinberger [Canada] ; Clement Hamani [Canada] ; William D. Hutchison [Canada] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada] | Pedunculopontine nucleus microelectrode recordings in movement disorder patients |
| 000528 |
J.-F. Gagnon [Canada] ; D. Petit [Canada] ; V. Latreille [Canada] ; J. Montplaisir [Canada] | Neurobiology of Sleep Disturbances in Neurodegenerative Disorders |
| 000536 |
Clement Hamani [Canada] ; Elena Moro [Canada] ; Cindy Zadikoff [Canada] ; Yu-Yan Poon [Canada] ; Andres M. Lozano [Canada] ; Philip A. Starr ; Julie G. Pilitsis ; Roy A. E. Bakay ; Robert G. Grossman | LOCATION OF ACTIVE CONTACTS IN PATIENTS WITH PRIMARY DYSTONIA TREATED WITH GLOBUS PALLIDUS DEEP BRAIN STIMULATION |
| 000547 |
Silke Paulmann [Allemagne, Canada] ; Marc D. Pell [Canada] ; Sonja A. Kotz [Allemagne] | Functional contributions of the basal ganglia to emotional prosody : Evidence from ERPs |
| 000548 |
Behnam A. Baghbaderani [Canada] ; Leo A. Behie [Canada] ; Arindom Sen [Canada] ; Karim Mukhida [Canada] ; Murray Hong [Canada] ; Ivar Mendez [Canada] | Expansion of Human Neural Precursor Cells in Large-Scale Bioreactors for the Treatment of Neurodegenerative Disorders |
| 000550 |
Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada] | Elevated Serotonin Transporter Binding in Depressed Patients with Parkinson's Disease : A Preliminary PET Study with [11C]DASB |
| 000551 |
Richard M. Camicioli [Canada] ; Marguerite Wieler [Canada] ; Cindy M. De Frias [Canada] ; W. R. Wayne Martin [Canada] | Early, untreated Parkinson's disease patients show reaction time variability |
| 000555 |
Brit Mollenhauer [États-Unis] ; Valerie Cullen [États-Unis] ; Ilana Kahn [États-Unis] ; Bryan Krastins [États-Unis] ; Tiago F. Outeiro [États-Unis] ; Imelda Pepivani [États-Unis] ; Juliana Ng [Canada] ; Walter Schulz-Schaeffer [Allemagne] ; Hans A. Kretzschmar [Allemagne] ; Pamela J. Mclean [États-Unis] ; Claudia Trenkwalder [Allemagne] ; David A. Sarracino [États-Unis] ; Jean-Paul Vonsattel [États-Unis] ; Joseph J. Locascio [États-Unis] ; Omar M. A. El-Agnaf [Émirats arabes unis] ; Michael G. Schlossmacher [États-Unis, Canada] | Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration |
| 000557 |
XIANG GAO [États-Unis] ; HONGLEI CHEN [États-Unis] ; Hyon K. Choi [États-Unis, Canada] ; Gary Curhan [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Alberto Ascherio [États-Unis] | Diet, Urate, and Parkinson's Disease Risk in Men |
| 000559 |
Teneille E. Gofton [Canada] ; Mandar Jog [Canada] | Diagnosing Parkinson's Disease : The Patient Perspective |
| 000561 |
Francois Tremblay [Canada] ; Guillaume Leonard [Canada] ; Louis Tremblay [Canada] | Corticomotor facilitation associated with observation and imagery of hand actions is impaired in Parkinson's disease |
| 000566 |
Jon B. Doan [Canada] ; Kyle G. Melvin [Canada] ; Ian Q. Whishaw [Canada] ; Oksana Suchowersky [Canada] | Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms |
| 000568 |
Nikolai V. Malykhin [Canada] ; Thomas P. Bouchard [Canada] ; Richard Camicioli [Canada] ; Nicholas J. Coupland [Canada] | Aging hippocampus and amygdala |
| 000570 |
Maria Fraraccio [Canada] ; Alain Ptito [Canada] ; Abbas Sadikot [Canada] ; Michel Panisset [Canada] ; Alain Dagher [Canada] | Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease |
| 000576 |
S. Potvin [Canada] ; S. Grignon [Canada] | Dopamine et douleur : une revue de littérature : Fibromyalgie |
| 000577 |
Julie Messier [Canada] ; Sergei Adamovich [États-Unis] ; David Jack [États-Unis] ; Wayne Hening [États-Unis] ; Jacob Sage [États-Unis] ; Howard Poizner [États-Unis] | Visuomotor learning in immersive 3D virtual reality in Parkinson's disease and in aging |
| 000580 |
Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | The role of anti-inflammatory agents in Parkinson's disease |
| 000581 |
Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | The role of anti-inflammatory agents in Parkinson's disease |
| 000584 |
Sarah Lemieux [Canada] ; Mehrdad Ghassemi [Canada] ; Mandar Jog [Canada] ; Roderick Edwards [Canada] ; Christian Duval [Canada] | The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease |
| 000589 |
Brigitte Stemmer [Canada] ; Sidney J. Segalowitz [Canada] ; Jane Dywan [Canada] ; Michel Panisset [Canada] ; Calvin Melmed [Canada] | The error negativity in nonmedicated and medicated patients with Parkinson's disease |
| 000592 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten-Year Follow-Up of Parkinson's Disease Patients Randomized to Initial Therapy with Ropinirole or Levodopa |
| 000601 |
Dominique Guehl [France] ; Roderick Edwards [Canada] ; Emmanuel Cuny [France] ; Pierre Burbaud [France] ; Alain Rougier [France] ; Julien Modolo [France] ; Anne Beuter [France] | Statistical determination of the optimal subthalamic nucleus stimulation site in patients with Parkinson disease |
| 000603 |
Jennifer E. Tobin [États-Unis] ; JING CUI [États-Unis] ; Jemma B. Wilk [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Jason M. Laramie [États-Unis] ; Ann C. Mckee [États-Unis] ; Mark Guttman [Canada] ; Samer Karamohamed [États-Unis] ; Anita L. Destefano [États-Unis] ; Richard H. Myers [États-Unis] | Sepiapterin reductase expression is increased in Parkinson's disease brain tissue |
| 000605 |
Adrian P. Fawcett [Canada] ; Daniel Cunic [Canada] ; Clement Hamani [Canada] ; Mojgan Hodaie [Canada] ; Andres M. Lozano [Canada] ; Robert Chen [Canada] ; William D. Hutchison [Canada] | Saccade-related potentials recorded from human subthalamic nucleus |
| 000617 |
Olivier Hue [Canada] ; Julie Marcotte [Canada] ; Félix Berrigan [Canada] ; Martin Simoneau [Canada] ; Jean Dore [Canada] ; Picard Marceau [Canada] ; Simon Marceau [Canada] ; Angelo Tremblay [Canada] ; Normand Teasdale [Canada] | Plasma concentration of organochlorine compounds is associated with age and not obesity |
| 000626 |
Alexandre Berney [Canada, Suisse] ; Michel Panisset [Canada] ; Abbas F. Sadikot [Canada] ; Alain Ptito [Canada] ; Alain Dagher [Canada] ; Maria Fraraccio [Canada] ; Ghislaine Savard [Canada] ; Marc Pell [Canada] ; Chawki Benkelfat [Canada] | Mood Stability during Acute Stimulator Challenge in Parkinson's Disease Patients Under Long-Term Treatment with Subthalamic Deep Brain Stimulation |
| 000627 |
Catherine R. Mcmillan [Canada] ; Rohita Sharma [Canada] ; Tom Ottenhof [Canada] ; Lennard P. Niles [Canada] | Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells |
| 000638 |
HAORAN WANG [Canada, République populaire de Chine] ; Mary X. Gao [Canada, Japon] ; LINDA LI [République populaire de Chine] ; BIN WANG [République populaire de Chine] ; Naohiro Hori [Japon] ; Kenzo Sato [Japon] | Isolation, expression, and characterization of the human ZCRB1 gene mapped to 12q12 |
| 000644 |
Raji Subramaniam [États-Unis] ; R. Sullivan [États-Unis] ; P. S. Schneider [États-Unis] ; T. Holden [États-Unis] ; G. Jr Tremberger [États-Unis] ; E. Cheung [États-Unis] ; A. Flamholz [États-Unis] ; D. H. Lieberman [États-Unis] ; T. D. Cheung [États-Unis] ; F. Garcia [États-Unis] ; N. Bewry [États-Unis] ; N. Pennie [États-Unis] | Intensity fluctuation analysis of cell scattering/imaging with clinical application |
| 000645 |
Henri Cohen [Canada] ; Emmanuelle Pourcher [Canada] | Intact encoding, impaired consolidation in procedural learning in Parkinson's disease |
| 000647 |
Ivan L. Cepeda [Canada] ; Joseph Flores [Canada] ; Michael L. Cornfeldt [États-Unis] ; John R. O'Kusky [Canada] ; Doris J. Doudet [Canada] | Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of parkinson disease |
| 000652 |
Laura Monetta [Canada] ; Marc D. Pell [Canada] | Effects of verbal working memory deficits on metaphor comprehension in patients with Parkinson's disease |
| 000653 |
Ron Levy [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada] ; Philip A. Starr ; Julie G. Pilitsis ; Roy A. E. Bakay | Dual microelectrode technique for deep brain stereotactic surgery in humans |
| 000656 |
M. Berk [Australie] ; S. Dodd [Australie] ; M. Kauer-Sant'Anna [Canada] ; G. S. Malhi [Australie] ; M. Bourin [France] ; F. Kapczinski [Brésil] ; T. Norman [Australie] | Dopamine dysregulation syndrome : implications for a dopamine hypothesis of bipolar disorder |
| 000667 |
Andrew S. Lim [Canada] ; Andres M. Lozano [Canada] ; Elena Moro [Canada] ; Clement Hamani [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] ; Anthony E. Lang [Canada] ; Richard A. Wennberg [Canada] ; Brian J. Murray [Canada] | Characterization of REM-sleep associated ponto-geniculo-occipital waves in the human pons |
| 000668 |
Joseph Flores [Canada] ; Ivan L. Cepeda [Canada] ; Michael L. Comfeldt [États-Unis] ; John R. O'Kusky [Canada] ; Doris J. Doudet [Canada] | Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of parkinson disease |
| 000676 |
Murray M. Finkelstein [Canada] ; Michael Jerrett [États-Unis] | A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities |
| 000686 |
Ysbrand D. Van Der Werf [Canada] ; Abbas F. Sadikot [Canada] ; Antonio P. Strafella [Canada] ; Tomas Paus [Canada, Royaume-Uni] | The neural response to transcranial magnetic stimulation of the human motor cortex. II. Thalamocortical contributions |
| 000688 |
Christian Duval [Canada] ; Michel Panisset [Canada] ; Antonio P. Strafella [Canada] ; Abbas F. Sadikot [Canada] | The impact of ventrolateral thalamotomy on tremor and voluntary motor behavior in patients with Parkinson's disease |
| 000697 |
J. Miklossy [Canada] ; D. D. Doudet [Canada] ; C. Schwab [Canada] ; S. Yu [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Role of ICAM-1 in persisting inflammation in parkinson disease and MPTP monkeys |
| 000708 |
Carl Julien [Canada] ; Line Berthiaume [Canada] ; Abdallah Hadj-Tahar [Canada] ; Ali H. Rajput [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] ; Pierre Julien [Canada] ; Frédéric Calon [Canada] | Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys |
| 000712 |
Kaveh M. Koochesfahani [Canada] ; Raul De La Fuente-Fernandez [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada] | Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients : Positron emission tomographic studies |
| 000713 |
Jon Doan [Canada] ; Ian Q. Whishaw [Canada] ; Sergio M. Pellis [Canada] ; Oksana Suchowersky [Canada] ; Lesley A. Brown [Canada] | Motor deficits in parkinsonian reaching : Dopa-sensitivity influenced by real-world task constraint |
| 000717 |
Judith Miklossy [Canada] ; Tetsuaki Arai [Japon] ; Jian-Ping Guo [Canada] ; Andis Klegeris [Canada] ; SHENG YU [Canada] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | LRRK2 expression in normal and pathologic human brain and in human cell lines |
| 000723 |
Cindy Zadikoff [Canada] ; Ekaterina Rogaeva [Canada] ; Ana Djarmati [Allemagne] ; Christine Sato [Canada] ; Shabnam Salehi-Rad [Canada] ; Peter St. George-Hyslop [Canada] ; Christine Klein [Canada, Allemagne] ; Anthony E. Lang [Canada] | Homozygous and heterozygous PINK1 mutations : Considerations for diagnosis and care of parkinson's disease patients |
| 000724 |
Zoran Todorovic [Serbie] ; Eleonora Dzoljic [Serbie] ; Ivana Novakovic [Serbie] ; Dusko Mirkovic [Serbie] ; Radan Stojanovic [Serbie] ; Zorica Nesic [Serbie] ; Maja Krajinovic [Canada] ; Milica Prostran [Serbie] ; Vladimir Kostic [Serbie] | Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy |
| 000728 |
G. Rasouli [Canada] ; M. Rasouli [Canada] ; F. A. Lenz [États-Unis] ; L. Verhagen [États-Unis] ; D. S. Borrett [Canada] ; H. C. Kwan [Canada] | Fractal characteristics of human parkinsonian neuronal spike trains |
| 000730 |
Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada] | Expectation and the placebo effect in parkinson's disease patients with subthalamic nucleus deep brain stimulation |
| 000734 |
Andrew R. Willan [Canada] ; Ron Goeree [Canada] ; Eleanor M. Pullenayegum [Canada] ; Christopher Mcburney [États-Unis] ; Gordon Blackhouse [Canada] | Economic evaluation of rivastigmine in patients with parkinson's disease dementia |
| 000746 |
Richa Saxena [États-Unis] ; Paul I. W. De Bakker [États-Unis] ; Karyn Singer [États-Unis] ; Vamsi Mootha [États-Unis] ; Noël Burtt [États-Unis] ; Joel N. Hirschhorn [États-Unis] ; Daniel Gaudet [Canada] ; Bo Isomaa [Finlande] ; Mark J. Daly [États-Unis] ; Leif Groop [Suède] ; Kristin G. Ardlie [États-Unis] ; David Altshuler [États-Unis] | Comprehensive association testing of common mitochondrial DNA variation in metabolic disease |
| 000747 |
Maryka Quik [États-Unis] ; Neeraja Parameswaran [États-Unis] ; Sarah E. Mccallum [États-Unis] ; Tanuja Bordia [États-Unis] ; SHANSHAN BAO [États-Unis] ; Alison Mccormack [États-Unis] ; Amy Kim [États-Unis] ; Rachel F. Tyndale [Canada] ; J. William Langston [États-Unis] ; Donato A. Di Monte [États-Unis] | Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates |
| 000749 |
Christian Duual [Canada] ; Abbas F. Sadikot [Canada] ; Michel Panisset [Canada] | Bradykinesia in patients with essential tremor |
| 000751 |
S. Mazza [Canada] ; J. P. Soucy [Canada] ; P. Gravel [Canada] ; M. Michaud [Canada] ; R. Postuma [Canada] ; J. Massicotte-Marquez [Canada] ; A. Decary [Canada] ; J. Montplaisir [Canada] | Assessing whole brain perfusion changes in patients with REM sleep behavior disorder |
| 000762 |
R. A. Bressan [Brésil] ; J. A. Crippa [Brésil] | The role of dopamine in reward and pleasure behaviour : review of data from preclinical research |
| 000763 |
Christian Duval [Canada] ; Antonio P. Strafella [Canada] ; Abbas F. Sadikot [Canada] | The impact of ventrolateral thalamotomy on high-frequency components of tremor |
| 000764 |
Christopher P. Bertram [Canada] ; Martin Lemay [Canada] ; George E. Stelmach [États-Unis] | The effect of Parkinson's disease on the control of multi-segmental coordination |
| 000771 |
Valerie Voon [Canada] ; Jean Saint-Cyr ; Andres M. Lozano ; Elena Moro ; YU YAN POON ; Anthony E. Lang | Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery |
| 000776 |
Kyle G. Melvin [Canada] ; Jon Doan [Canada] ; Sergio M. Pellis [Canada] ; Lesley Brown [Canada] ; Ian Q. Whishaw [Canada] ; Oksana Suchowersky [Canada] | Pallidal deep brain stimulation and L-dopa do not improve qualitative aspects of skilled reaching in parkinson's disease |
| 000785 |
Guy Chouinard [Canada] ; Howard C. Margolese [Canada] | Manual for the Extrapyramidal Symptom Rating Scale (ESRS) |
| 000789 |
Anthony O'Hagan [Royaume-Uni] ; Christopher Mccabe [Royaume-Uni] ; Ron Akehurst [Royaume-Uni] ; Alan Brennan [Royaume-Uni] ; Andrew Briggs [Royaume-Uni] ; Karl Claxton [Royaume-Uni] ; Elisabeth Fenwick [Royaume-Uni] ; Dennis Fryback [États-Unis] ; Mark Sculpher [Royaume-Uni] ; David Spiegelhalter [Royaume-Uni] ; Andrew Willan [Canada] | Incorporation of uncertainty in health economic modelling studies |
| 000790 |
Ned Jenkinson [Royaume-Uni] ; Dipankar Nandi [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] ; John F. Stein [Royaume-Uni] ; Paolo Mazzone [Italie] ; Andres Lozano [Canada] ; Paolo Stanzione [Italie] ; Salvatore Galati [Italie] ; Eugenio Scarnati [Italie] ; Antonella Peppe [Italie] ; Alessandro Stefani [Italie] | Implantation of human pedunculopontine nucleus : a safe and clinically relevant target in Parkinson's disease. Commentary |
| 000791 |
Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] | Identification of motor and nonmotor wearing-off in Parkinson's disease : Comparison of a patient questionnaire versus a clinician assessment |
| 000792 |
Jennifer Kachergus [États-Unis] ; Ignacio F. Mata [États-Unis] ; Mary Hulihan [États-Unis] ; Julie P. Taylor [États-Unis] ; Sarah Lincoln [États-Unis] ; Jan Aasly [États-Unis] ; J. Mark Gibson [Canada] ; Owen A. Ross [États-Unis, Royaume-Uni] ; Timothy Lynch [Royaume-Uni, Pays-Bas] ; Joseph Wiley [Royaume-Uni, Pays-Bas] ; Haydeh Payami [États-Unis] ; John Null [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Krzysztof Czyzewski [Pologne] ; Maria Styczynska [Pologne] ; Zbigniew K. Wszolek [États-Unis] ; Matthew J. Farrer [États-Unis] ; Mathias Toh [États-Unis, Norvège] | Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism : Evidence of a common founder across European populations |
| 000794 |
Julie-Christine Levesque [Canada] ; André Parent [Canada] | GABAergic interneurons in human subthalamic nucleus |
| 000795 |
Joyce K. H. Tang [Canada] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada] ; Neil Mahant [Canada] ; Jonathan O. Dostrovsky [Canada] | Firing rates of pallidal neurons are similar in Huntington's and Parkinson's disease patients |
| 000797 |
Adrian P. Fawcett [Canada] ; Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada] | Eye movement-related responses of neurons in human subthalamic nucleus |
| 000799 |
James G. Perretta [Canada] ; Giovanna Pari [Canada] ; Richard J. Beninger [Canada] | Effects of parkinson disease on two putative nondeclarative learning tasks : Probabilistic classification and gambling |
| 000805 |
Florence Chan [Canada] ; Irene T. Armstrong [Canada] ; Giovanna Pari [Canada] ; Richard J. Riopelle [Canada] ; Douglas P. Munoz [Canada] | Deficits in saccadic eye-movement control in Parkinson's disease |
| 000806 |
Thomas E. Marler [États-Unis] ; Vivian Lee [Canada] ; Christopher A. Shaw [Canada] | Cycad toxins and neurological diseases in guam : Defining theoretical and experimental standards for correlating human disease with environmental toxins |
| 000812 |
Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada] | Chymotrypsin-like proteases contribute to human monocytic THP-1 cell as well as human microglial neurotoxicity |
| 000815 |
Deniz Kirik [Suède] ; Anders Björklund [Suède] ; Ivar Mendez [Canada] ; Rosario Sanchez-Pernaute [États-Unis] ; Oliver Cooper [États-Unis] ; Angel Vinuela [États-Unis] ; Daniela Ferrari [États-Unis] ; Lars Björklund [États-Unis] ; Alain Dagher [Canada] ; Ole Isacson [États-Unis] | Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Commentary |
| 000826 |
Tom H. Johnston [Canada] ; Joohyung Lee [Canada] ; Jordi Gomez-Ramirez [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] | A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease |
| 000828 |
Anna Moszczynska [Canada] ; Paul Fitzmaurice [Canada] ; Lee Ang [Canada] ; Kathryn S. Kalasinsky [États-Unis] ; Gregory A. Schmunk [États-Unis] ; Frank J. Peretti [États-Unis] ; Sally S. Aiken [États-Unis] ; Dennis J. Wickham [États-Unis] ; Stephen J. Kish [Canada] | Why is parkinsonism not a feature of human methamphetamine users? |
| 000830 |
Colleen P. Millikin [Canada] ; Lisa L. Trepanier [Canada] ; Sean B. Rourke [Canada] | Verbal fluency component analysis in adults with HIV/AIDS |
| 000831 |
Brian Harel [États-Unis] ; Michael Cannizzaro [États-Unis] ; Peter J. Snyder [États-Unis, Canada] | Variability in fundamental frequency during speech in prodromal and incipient Parkinson's disease: A longitudinal case study |
| 000832 |
Jason A. Brodkey [Canada] ; Ronald R. Tasker ; Clement Hamani ; Mary Pat Mcandrews ; Jonathan O. Dostrovsky ; Andres M. Lozano | Tremor cells in the human thalamus: differences among neurological disorders |
| 000834 |
L. Clark [Royaume-Uni] ; R. Cools [Royaume-Uni] ; T. W. Robbins [Royaume-Uni] | The neuropsychology of ventral prefrontal cortex: Decision-making and reversal learning |
| 000836 |
Christian Duval [Canada] ; Abbas F. Sadikot [Canada] ; Michel Panisset [Canada] | The detection of tremor during slow alternating movements performed by patients with early Parkinson's disease |
| 000837 |
Alexander Zimprich [Allemagne] ; Bertram Müller-Myhsok [États-Unis] ; Matthew Farrer [États-Unis] ; Petra Leitner [Allemagne] ; Manu Sharma [Allemagne] ; Mary Hulihan [États-Unis] ; Paul Lockhart [États-Unis] ; Audrey Strongosky [États-Unis] ; Jennifer Kachergus [États-Unis] ; Donald B. Calne [Canada] ; Jon Stoessl [Canada] ; Ryan J. Uitti [États-Unis] ; Ronald F. Pfeiffer [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Nikolaus Homann [Autriche] ; Erwin Ott [Autriche] ; Karoline Wenzel [Autriche] ; Friedrich Asmus [Allemagne] ; John Hardy [Royaume-Uni] ; Zbigniew Wszolek [États-Unis] ; Thomas Gasser [Allemagne] | The PARK8 locus in autosomal dominant Parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval |
| 000840 |
Marcelo T. Mira [Canada, Brésil, France, Viêt Nam, Pays-Bas] ; Alexandre Alcaïs ; NGUYEN VAN THUC ; Milton O. Moraes ; Celestino Di Flumeri ; VU HONG THAI ; MAL CHI PHUONG ; NGUYEN THU HUONG ; NGUYEN NGOC BA ; PHAM XUAN KHOA ; Euzenir N. Sarno ; Andrea Alter ; Alexandre Montpetit ; Marla E. Moraes ; José R. Moraes ; Carole Dore ; Caroline J. Dallant ; Pierre Lepage ; Andrel Verner ; Esther Van De Vosse ; Thomas J. Hudson ; Laurent Abel ; Erwin Schurr | Susceptibility to leprosy is associated with PARK2 and PACRG |
| 000843 |
Mohammed Filali [Canada] ; William D. Hutchison [Canada] ; Vanessa N. Palter [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada] | Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus |
| 000844 |
Ritsuko Hanajima [Canada] ; Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada] ; Karen D. Davis [Canada] ; Robert Chen [Canada] ; Peter Ashby [Canada] | Somatosensory evoked potentials (SEPs) recorded from deep brain stimulation (DBS) electrodes in the thalamus and subthalamic nucleus (STN) |
| 000847 |
M. A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; P. Ravenscroft [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; M. J. Millan [France] ; J. M. Brotchie [Canada] | Selective blockade of D3 dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate |
| 000854 |
Ajmal Razmy [Canada] ; Anthony E. Lang [Canada] ; Colin M. Shapiro [Canada] | Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists |
| 000855 |
Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] | Postural control during a sit-to-stand task in individuals with mild Parkinson's disease |
| 000857 |
R. M. Camicioli [Canada] ; J. R. Korzan [Canada] ; S. L. Foster [Canada] ; N. J. Fisher [Canada] ; D. J. Emery [Canada] ; A. C. Bastos [Canada] ; C. C. Hanstock [Canada] | Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia |
| 000858 |
Raul De La Fuente-Fernandez [Canada, Espagne] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] | Placebo mechanisms and reward circuitry: Clues from Parkinson's disease |
| 000861 |
D. J. Doudet [Canada] ; M. L. Cornfeldt [États-Unis] ; C. R. Honey [Canada] ; A. W. Schweikert [États-Unis] ; R. C. Allen [États-Unis] | PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of parkinson's disease |
| 000863 |
Luiz C. M. Pereira [Canada] ; Vanessa N. Palter [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada] | Neuronal activity in the globus pallidus of multiple system atrophy patients |
| 000865 |
Richard Camicioli [Canada] ; Lisa Licis [Canada] | Motor impairment predicts falls in specialized Alzheimer care units |
| 000870 |
Y. Kumakura [Danemark] ; E. H. Danielsen [Danemark] ; A. Reilhac [Canada] ; A. Gjedde [Danemark, Canada] ; P. Cumming [Danemark] | Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease |
| 000873 |
Frédéric Calon [Canada] ; Mehdi Dridi [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada] | Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias |
| 000874 |
Ronald B. Postuma [Canada] ; Anthony E. Lang [Canada] | Homocysteine and levodopa: Should Parkinson disease patients receive preventative therapy? |
| 000875 |
Mark D. Berry [Canada] | Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders |
| 000885 |
Anne Beuter [Canada] ; Roderick Edwards [Canada] | Effect of chronic exposure to methylmercury on eye movements in Cree subjects |
| 000890 |
E. Tunik [États-Unis] ; H. Poizner [États-Unis] ; S. V. Adamovich [États-Unis] ; M. F. Levin [Canada] ; A. G. Feldman [Canada] | Deficits in adaptive upper limb control in response to trunk perturbations in Parkinson's disease |
| 000903 |
Ajit Kumar [Canada] ; Sharanpal Mann [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] ; Chong S. Lee [Canada] | [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease |
| 000904 |
Susan M. Calne [Canada] ; Edwin Mak [Canada] ; Jeanne Hall [Canada] ; Marie-Jose Fortin [Canada] ; Pamela King [Canada] ; Germaine Mcinnes [Canada] ; Linda Grantier [Canada] ; Sherree Trecartin [Canada] ; Michael Schulzer [Canada] | Validating a quality-of-life scale in caregivers of patients with Parkinson's disease: Parkinson's impact scale (PIMS) |
| 000905 |
Carlo Pappone [Italie] ; Vincenzo Santinelli [Italie] ; Salvatore Rosanio [Italie] ; Gabriele Vicedomini [Italie] ; Stefano Nardi [Italie] ; Alessia Pappone [Italie] ; Valter Tortoriello [Italie] ; Francesco Manguso [Italie] ; Patrizio Mazzone [Italie] ; Simone Gulletta [Italie] ; Giuseppe Oreto [Italie] ; Ottavio Alfieri [Canada] ; Derick M. Todd [Canada] ; George J. Klein [Canada] ; Andrew D. Krahn [Canada] ; Allan C. Skanes [Canada] ; Raymond Yee [Canada] | Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-white pattern: Results from a large prospective long-term follow-up study. Commentary |
| 000906 |
Henrik Sjöström [Suisse] ; John H. J. Allum [Suisse] ; Mark G. Carpenter [Canada] ; Allan L. Adkin [Canada] ; Flurin Honegger [Suisse] ; Thierry Ettlin [Suisse] | Trunk sway measures of postural stability during clinical balance tests in patients with chronic whiplash injury symptoms |
| 000907 |
Joseph King Ching Tsui [Canada] | Treatment of dystonia in Parkinson's disease |
| 000908 |
W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada] | Treatment of Parkinson's disease |
| 000909 |
Roger F. Butterworth [Canada] | Thiamin deficiency and brain disorders |
| 000910 |
Pierre J. Blanchet [Canada] | The fluctuating Parkinsonian patient: Clinical and pathophysiological aspects |
| 000912 |
Andres M. Lozano [Canada] | Surgery for Parkinson's disease, the five W's: Why, who, what, where, and when |
| 000913 |
Antonio P. Strafella [Canada] ; Abbas F. Sadikot [Canada] ; Alain Dagher [Canada] | Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease |
| 000914 |
Antonio P. Strafella [Canada] ; Tomas Paus [Canada] ; Maria Fraraccio [Canada] ; Alain Dagher [Canada] | Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex |
| 000915 |
Aviva Abosch [Canada] ; Shitij Kapur [Canada] ; Anthony E. Lang [Canada] ; Doug Hussey [Canada] ; Elspeth Sime [Canada] ; Janis Miyasaki [Canada] ; Svlvain Houle [Canada] ; Andres M. Lozano [Canada] ; Philip Starr ; Giovanni Broggi ; Roy A. E. Bakay ; Nicholas Boulis ; Ali R. Rezai | Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Commentary |
| 000916 |
Aviva Abosch [Canada] ; Andres Lozano [États-Unis] | Stereotactic neurosurgery for movement disorders |
| 000917 |
Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias [Canada] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni] | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study |
| 000918 |
Basta Maria [Grèce] ; Schiza Sophia [Grèce] ; Mauridis Michalis [Grèce] ; Lydakis Charalampos [Grèce] ; Plaitakis Andreas [Grèce] ; Milic Emili John [Canada] ; Siafakas M. Nikolaos [Grèce] | Sleep breathing disorders in patients with idiopathic Parkinson's disease |
| 000919 |
Alexandra Sailer [Canada, Allemagne] ; Gregory F. Molnar [Canada] ; Guillermo Paradiso [Canada] ; Carolyn A. Gunraj [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Short and long latency afferent inhibition in Parkinson's disease |
| 000920 |
Pierre J. Blanchet [États-Unis, Canada] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] | Renaissance of amantadine in the treatment of Parkinson's disease |
| 000921 |
K. Fuxe [Suède] ; L. F. Agnati [Italie] ; K. Jacobsen [Canada] ; J. Hillion [États-Unis] ; M. Canals [Espagne] ; M. Torvinen [Suède] ; B. Tinner-Staines [Canada] ; W. Staines [Canada] ; D. Rosin [États-Unis] ; A. Terasmaa [Suède] ; P. Popoli [Italie] ; G. Leo [Italie] ; V. Vergoni [Italie] ; C. Lluis [Espagne] ; F. Ciruela [Espagne] ; R. Franco [Espagne] ; S. Ferre [États-Unis] | Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson's disease |
| 000923 |
Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Anthony E. Lang [Canada] ; Irene Litvan [États-Unis] | Progression of gait, speech and swallowing deficits in progressive supranuclear palsy |
| 000924 |
Marc D. Pell [Canada] ; Carol L. Leonard [Canada] | Processing emotional tone from speech in Parkinson's disease: A role for the basal ganglia |
| 000926 |
Patrick L. Mcgeer [Canada] ; Claudia Schwab [Canada] ; Andre Parent [Canada] ; Doris Doudet [Canada] | Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration |
| 000927 |
Simon Lemay [Canada] ; Pierre Blanchet [Canada] ; Sylvain Chouinard [Canada] ; Hélène Masson [Canada] ; Valérie Soland [Canada] ; Marc-André Bedard [Canada] | Poor tolerability of a transdermal nicotine treatment in Parkinson's disease |
| 000928 |
Sophie Vigouroux [France] ; Yoshiaki Furukawa [Canada] ; Luc Farout [France] ; Stephen J. Kish [Canada] ; Marièle Briand [France] ; Yves Briand [France] | Peptidase activities of the 20/26S proteasome and a novel protease in human brain |
| 000929 |
Richard Camicioli [États-Unis, Canada] ; M. Milar Moore [États-Unis] ; Anthony Kinney [États-Unis] ; Elizabeth Corbridge [États-Unis] ; Kathryn Glassberg [États-Unis] ; Jeffrey A. Kaye [États-Unis] | Parkinson's disease is associated with hippocampal atrophy |
| 000930 |
S. Lincoln [États-Unis] ; J. Wiley [Irlande (pays)] ; T. Lynch [Irlande (pays)] ; J. W. Langston [États-Unis] ; R. Chen [États-Unis] ; A. Lang [Canada] ; E. Rogaeva [Canada] ; D. S. Sa [Canada] ; R. P. Munhoz [Canada] ; J. Harris [États-Unis] ; K. Marder [États-Unis] ; C. Klein [Allemagne] ; G. Bisceglio [États-Unis] ; J. Hussey [États-Unis] ; A. West [États-Unis] ; M. Hulihan [États-Unis] ; J. Hardy [États-Unis] ; M. Farrer [États-Unis] | Parkin-proven disease: Common founders but divergent phenotypes |
| 000931 |
William D. Hutchison [Canada] ; Anthony E. Lang [Canada] ; Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] | Pallidal neuronal activity: Implications for models of dystonia |
| 000935 |
Paul S. Fitzmaurice [Canada] ; LEE ANG [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] | Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease |
| 000936 |
S. Warby [Canada] | New mutations, new etiologies for Parkinson disease |
| 000937 |
A. Hadj Tahar [Canada] ; R. Grondin [Canada] ; L. Gregoire [Canada] ; F. Calon [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada] | New insights in Parkinson's disease therapy: Can levodopa-induced dyskinesia ever be manageable |
| 000940 |
Galit Kleiner-Fisman [Canada] ; David N. Fisman [Canada] ; Farooq I. Kahn [Canada] ; Elspeth Sime [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Motor cortical stimulation for parkinsonism in multiple system atrophy |
| 000941 |
Ajit Kumar [Canada] ; ZHIGAO HUANG [Canada] ; Raul De La Fuente-Fernandez [Canada] | Mechanisms of motor complications in treatment of Parkinson's disease |
| 000942 |
Douglas Coyle [Canada] ; Martin J. Buxton [Royaume-Uni] ; Bernie J. O'Brien [Canada] | Measures of importance for economic analysis based on decision modeling |
| 000943 |
Larissa Takser [France] ; Donna Mergler [Canada] ; Georgette Hellier [France] ; Josiane Sahuquillo [France] ; Guy Huel [France] | Manganese, monoamine metabolite levels at birth, and child psychomotor development |
| 000945 |
Galit Kleiner-Fisman [Canada] ; David N. Fisman ; Elspeth Sime ; Jean A. Saint-Cyr ; Andres M. Lozano ; Anthony E. Lang | Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease |
| 000946 |
Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon Stoessl [Canada] | Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair |
| 000947 |
Z. H. T. Kiss [Canada] ; K. D. Davis [Canada] ; R. R. Tasker [Canada] ; A. M. Lozano [Canada] ; B. Hu [Canada] ; J. O. Dostrovsky [Canada] | Kinaesthetic neurons in thalamus of humans with and without tremor |
| 000949 |
Richard A. Wennberg [Canada] ; Andres M. Lozano [Canada] | Intracranial volume conduction of cortical spikes and sleep potentials recorded with deep brain stimulating electrodes |
| 000952 |
Yoshiaki Furukawa [Canada] | Genetics and biochemistry of dopa-responsive dystonia: Significance of striatal tyrosine hydroxylase protein loss |
| 000953 |
Allan L. Adkin [Canada] ; James S. Frank [Canada] ; Mandar S. Jog [Canada] | Fear of falling and postural control in Parkinson's disease |
| 000954 |
Kelly L. Jordan-Sciutto [États-Unis] ; Robert Dorsey [États-Unis] ; Elisabeth M. Chalovich [États-Unis] ; Robert R. Hammond [Canada] ; Cristian L. Achim [États-Unis] | Expression patterns of retinoblastoma protein in Parkinson disease |
| 000955 |
ZHIGAO HUANG [Canada] ; Raul De La Fuente-Fernandez [Canada] ; A. Jon Stoessl [Canada] | Etiology of Parkinson's disease |
| 000957 |
Alex Rajput [Canada] ; Michele Rajput [Canada] | Essential tremor and Parkinsonism |
| 000958 |
V. Sossi [Canada] ; J. E. Holden [États-Unis] ; R. De La Fuente-Fernandez [Canada] ; T. J. Ruth [Canada] ; A. J. Stoessl [Canada] | Effect of dopamine loss and the metabolite 3-O-methyl-[18F]fluoro-dopa on the relation between the 18F-fluorodopa tissue input uptake rate constant KOCC and the [18F]fluorodopa plasma input uptake rate constant Ki |
| 000960 |
Stephen Hague [Canada] ; Ekaterina Rogaeva [Canada] ; Dena Hernandez [Canada] ; Cindy Gulick [Canada] ; Amanda Singleton [États-Unis] ; Melissa Hanson [États-Unis] ; Janel Johnson [Canada] ; Roberto Weiser [Venezuela] ; Marisol Gallardo [Venezuela] ; Bernard Ravina [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Anthony Crawley [États-Unis] ; Peter H. St. George-Hyslop [Canada] ; Anthony E. Lang [Canada] ; Peter Heutink [Pays-Bas] ; Vincenzo Bonifati [Pays-Bas, Italie] ; John Hardy [États-Unis] ; Andrew Singleton [Canada] | Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation |
| 000961 |
A. Jon Stoessl [Canada] ; Raul De La Fuente-Fernandez [Canada] | Dopamine receptors in Parkinson's disease: Imaging studies |
| 000965 |
Michael Iskedjian [Canada] ; Thomas R. Einarson [Canada] | Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease |
| 000967 |
Mahyar Etminan [Canada] ; Sudeep Gill [Canada] ; Ali Samii [États-Unis] | Comparison of the risk of adverse events with Pramipexole and ropinirole in patients with Parkinson's disease a meta-analysis |
| 000968 |
G. V. Mcdonnell [Canada] ; J. Cabrera-Gomez [Canada] ; D. B. Calne [Canada] ; D. K. B. Li [Canada] ; J. Oger [Canada] | Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: The subclinical stage of primary progressive multiple sclerosis may last 10 years |
| 000969 |
Doug Everett Hobson [Canada] | Clinical manifestations of Parkinson's disease and parkinsonism |
| 000971 |
Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications |
| 000972 |
Antonio P. Strafella [Canada] ; Alain Dagher [Canada] ; Abbas F. Sadikot [Canada] | Cerebral blood flow changes induced by subthalamic stimulation in Parkinson's disease |
| 000973 |
Mark Guttman [Canada] ; Pamela M. Slaughter [Canada] ; Marc-Erick Theriault [Canada] ; Donald P. Deboer [Canada] ; C. David Naylor [Canada] | Burden of parkinsonism: A population-based study |
| 000974 |
Stephen J. Kish [Canada] | Biochemistry of Parkinson's disease: Is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? |
| 000975 |
D. J. Brooks [Royaume-Uni] ; K. A. Frey [États-Unis] ; K. L. Marek [États-Unis] ; D. Cakes [États-Unis] ; D. Paty [Canada] ; R. Prentice [États-Unis] ; C. W. Shults [États-Unis] ; A. J. Stoessl [Canada] | Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease |
| 000976 |
Jason A. R. Carr [Canada] ; Christopher R. Honey ; Marci Sinden ; Anthony G. Phillips ; Jeffrey S. Martzke | A waitlist control-group study of cognitive, mood, and quality of life outcome after posteroventral pallidotomy in Parkinson disease |
| 000978 |
S. Karamohamed [États-Unis] ; A. L. Destefano [États-Unis] ; J. B. Wilk [États-Unis] ; C. M. Shoemaker [États-Unis] ; L. I. Golbe [États-Unis] ; M. H. Mark [États-Unis] ; A. M. Lazzarini [États-Unis] ; O. Suchowersky [Canada] ; N. Labelle [Canada] ; M. Guttman [Canada] ; L. J. Currie [États-Unis] ; G. F. Wooten [États-Unis] ; M. Stacy [États-Unis] ; M. Saint-Hilaire [États-Unis] ; R. G. Feldman [États-Unis] ; K. M. Sullivan [États-Unis] ; G. Xu [États-Unis] ; R. Watts [États-Unis] ; J. Growdon [États-Unis] ; M. Lew [États-Unis] ; C. Waters [États-Unis] ; P. Vieregge [Allemagne] ; P. P. Pramstaller [Italie] ; C. Klein [Allemagne] ; B. A. Racette [États-Unis] ; J. S. Perlmutter [États-Unis] ; A. Parsian [États-Unis] ; C. Singer [États-Unis] ; E. Montgomery [États-Unis] ; K. Baker [États-Unis] ; J. F. Gusella [États-Unis] ; S. J. Fink [États-Unis] ; R. H. Myers [États-Unis] ; A. Herbert [États-Unis] | A haplotype at the PARK3 locus influences onset age for Parkinson's disease: The GenePD study |
| 000979 |
C. Warren Olanow [États-Unis] ; Christopher G. Goetz [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; A. Jon Stoessl [Canada] ; Vesna Sossi [Canada] ; Mitchell F. Brin [États-Unis] ; Kathleen M. Shannon [États-Unis] ; G. Michael Nauert [États-Unis] ; Daniel P. Perl [États-Unis] ; James Godbold [États-Unis] ; Thomas B. Freeman [États-Unis] | A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's Disease |
| 000980 |
Robert Jr Laforce [Canada] | Revue des mécanismes d'apprentissage par lesquels le striatum participe à l'apprentissage implicite d'habiletés |
| 000981 |
J.-F. Gagnon [Canada] ; J. Montplaisir [Canada] ; M.-A. Bedard [Canada] | Les troubles du sommeil paradoxal dans la maladie de Parkinson |
| 000982 |
Anne-Geneviève Herbaut [Belgique] | Le plancher pelvien neurologique et le gastro-entérologue |
| 000983 |
A. Beuter [Canada] ; R. Edwards [Canada] | Caractérisation et discrimination du tremblement cinétique dans la maladie de Parkinson |
| 000984 |
Anette V. Nieves [Canada, États-Unis] ; Anthony E. Lang [Canada] | Treatment of excessive daytime sleepiness in patients with Parkinson's Disease with modafinil |
| 000986 |
Todd S. Woodward [Canada] ; Daniel N. Bub [Canada] ; Michael A. Hunter [Canada] | Task switching deficits associated with Parkinson's disease reflect depleted attentional resources |
| 000987 |
H. Christopher Hyson [Canada] ; Andrew M. Johnson [Canada] ; Mandar S. Jog [Canada] | Sublingual atropine for sialorrhea secondary to parkinsonism: A pilot study |
| 000989 |
H. Uri Saragovi [Canada] ; Maria Clara Zaccaro [Canada] | Small molecule peptidomimetic ligands of neurotrophin receptors, identifying binding sites, activation sites and regulatory sites |
| 000990 |
R. Levy [Canada] ; A. E. Lang [Canada] ; W. D. Hutchison [Canada] ; A. M. Lozano [Canada] ; J. O. Dostrovsky [Canada] | Simultaneous repetitive movements following pallidotomy or subthalamic deep brain stimulation in patients with Parkinson's disease |
| 000991 |
Ivar Mendez [Canada] ; Alain Dagher ; Murray Hong ; Paula Gaudet ; Swarna Weerasinghe ; Vivian Mcalister ; David King ; Jacques Desrosiers ; Sultan Darvesh ; Tanya Acorn ; Harold Robertson | Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study: Report of three cases |
| 000992 |
T. A. Greenwood [États-Unis] ; M. Alexander [États-Unis] ; P. E. Keck [États-Unis] ; S. Mcelroy [États-Unis] ; A. D. Sadovnick [Canada] ; R. A. Remick [Canada] ; S. H. Jr Shaw [États-Unis] ; J. R. Kelsoe [États-Unis] | Segmental linkage disequilibrium within the dopamine transporter gene |
| 000993 |
Vincenzo Di Matteo [Italie] ; Marisa Cacchio [Italie] ; Camillo Di Giulio [Italie] ; Ennio Esposito [Italie] | Role of serotonin2C receptors in the control of brain dopaminergic function |
| 000996 |
Connie Marras [Canada] ; Paula Rochon [Canada] ; Anthony E. Lang [Canada] | Predicting motor decline and disability in Parkinson disease: A systematic review |
| 000997 |
M. Guttman [Canada] ; P. M. Slaughter [Canada] ; M.-E. Theriault [Canada] ; D. P. Deboer [Canada] ; C. D. Naylor [Canada] | Parkinsonism in Ontario: Physician utilization |
| 000A01 |
Jeffrey D. Atkinson [Canada] ; D. Louis Collins ; Gilles Bertrand ; Terry M. Peters ; G. Bruce Pike ; Abbas F. Sadikot | Optimal location of thalamotomy lesions for tremor associated with Parkinson disease: a probabilistic analysis based on postoperative magnetic resonance imaging and an integrated digital atlas |
| 000A03 |
Mohamed Shafiq [Canada] ; Anthony E. Lang [Canada] | Myoclonus in parkinsonian disorders |
| 000A04 |
Aviva Abosch [Canada] ; William D. Hutchison ; Jean A. Saint-Cyr ; Jonathan O. Dostrovsky ; Andres M. Lozano | Movement-related neurons of the subthalamic nucleus in patients with Parkinson disease |
| 000A05 |
Andres M. Lozano [Canada] ; William D. Hutchison [Canada] | Microelectrode recordings in the pallidum |
| 000A07 |
Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] | Mechanisms of deep brain stimulation |
| 000A08 |
Jean A. Saint-Cyr [Canada] ; Tasnuva Hoque ; Luiz C. M. Pereira ; Jonathan O. Dostrovsky ; William D. Hutchison ; David J. Mikulis ; Aviva Abosch ; Elspeth Sime ; Anthony E. Lang ; Andres M. Lozano | Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging |
| 000A09 |
David A. Grimes [Canada] ; J. David Grimes [Canada] ; Lem Racacho [Canada] ; Kylie A. Scoggan [Canada] ; Fabin Han [Canada] ; Betty Anne Schwarz [Canada] ; John Woulfe [Canada] ; Dennise Bulman [Canada] | Large French-Canadian family with Lewy body parkinsonism: Exclusion of known loci |
| 000A10 |
André Parent [Canada] ; Martin Parent [Canada] ; Véronique Leroux-Hugon [France] | Jules Bernard Luys: A singular figure of 19th Century neurology |
| 000A13 |
Frédéric Calon [Canada] ; Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias |
| 000A14 |
Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Canada] ; James E. Holden [États-Unis] ; Doris J. Doudet [Canada] ; Jess Mckenzie [Canada] ; A. J. Stoessl [Canada] ; T. J. Ruth [Canada] | Increase in dopamine turnover occurs early in Parkinson's disease: Evidence from a new modeling approach to PET 18F-fluorodopa data |
| 000A16 |
Ian Q. Whishaw [Canada] ; Oksana Suchowersky [Canada] ; Leigh Davis [Canada] ; Justyna Sarna [Canada] ; Gerlinde A. Metz [Canada] ; Sergio M. Pellis [Canada] | Impairment of pronation, supination, and body co-ordination in reach-to-grasp tasks in human Parkinson's disease (PD) reveals homology to deficits in animal models |
| 000A19 |
Allan L. Adkin [Canada] ; James S. Frank [Canada] ; Mark G. Carpenter [Canada] ; Gerhard W. Peysar [Canada] | Fear of falling modifies anticipatory postural control |
| 000A20 |
Douglas E. Hobson [Canada] ; Anthony E. Lang [Canada] ; W. R. Wayne Martin [Canada] ; Ajmal Razmy [Canada] ; Jean Rivest [Canada] ; Jonathan Fleming [Canada] | Excessive daytime Sleepiness and sudden-onset Sleep in Parkinson disease: A survey by the Canadian Movement Disorders Group |
| 000A22 |
Michel Cyr [Canada] ; Frederic Calon [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease |
| 000A23 |
N. E. Maher [États-Unis, Canada, Allemagne, Italie] ; L. I. Golbe ; A. M. Lazzarini ; M. H. Mark ; L. J. Currie ; G. F. Wooten ; M. Saint-Hilaire ; J. B. Wilk ; J. Volcjak ; J. E. Maher ; R. G. Feldman ; M. Guttman ; M. Lew ; S. Schuman ; O. Suchowersky ; A. L. Lafontaine ; N. Labelle ; P. Vieregge ; P. P. Pramstaller ; C. Klein ; J. Hubble ; C. Reider ; J. Growdon ; R. Watts ; E. Montgomery ; K. Baker ; C. Singer ; M. Stacy ; R. H. Myers | Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study |
| 000A26 |
A. Berney [Suisse, Canada] ; F. Vingerhoets [Suisse] ; A. Perrin [Suisse] ; P. Guex [Suisse] ; J.-G. Villemure [Suisse] ; P. R. Burkhard [Suisse] ; C. Benkelfat [Canada] ; J. Ghika [Suisse] | Effect on mood of subthalamic DBS for Parkinson's disease: A consecutive series of 24 patients |
| 000A28 |
Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; Mariangela Zamburlini [Canada] ; Vesna Sossi [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Dopamine release in human ventral striatum and expectation of reward |
| 000A29 |
C. E. Clarke [Royaume-Uni] ; M. Guttman [Canada] | Dopamine agonist monotherapy in Parkinson's disease |
| 000A31 |
Robert Jr Laforce [Canada] ; Julien Doyon [Canada] | Differential role for the striatum and cerebellum in response to novel movements using a motor learning paradigm |
| 000A32 |
Ron Levy [Canada] ; Peter Ashby [Canada] ; William D. Hutchison [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada] | Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease |
| 000A33 |
Anthony E. Lang [Canada] ; Hakan Widner [Suède] | Deep brain stimulation for Parkinson's disease: Patient selection and evaluation |
| 000A36 |
Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada] | Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP |
| 000A37 |
Nicole Duchesne [Canada] ; Jean-Paul Soucy [Canada] ; Hélène Masson [Canada] ; Sylvain Chouinard [Canada] ; Marc-André Bedard [Canada] | Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: A single photon emission computed tomography study using 123Iodine-β-CIT in patients on and OFF levodopa |
| 000A38 |
Azi H. Rajput [Canada] ; Mark E. Fenton [Canada] ; Sam Birdi [Canada] ; Rob Macaulay [Canada] ; David George [Canada] ; Bohdar Rozdilsky [Canada] ; Lee C. Ang [Canada] ; Ambikaipakan Senthilselvan [Canada] ; Oleh Hornykiewicz [Autriche] | Clinical-pathological study of levodopa complications |
| 000A39 |
Yoshiaki Furukawa [Canada] ; Sophie Vigouroux [France] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; LEE ANG [Canada] ; Marièle Briand [France] ; Stephen J. Kish [Canada] ; Yves Briand [France] | Brain proteasomal function in sporadic Parkinson's disease and related disorders |
| 000A41 |
Patrick L. Mcgeer [Canada] ; Koji Yasojima [Canada] ; Edith G. Mcgeer [Canada] | Association of interleukin-1β polymorphisms with idiopathic Parkinson's disease |
| 000A44 |
J. M. Woulfe [Canada] ; R. Duke [Canada] ; J. M. Middeldorp [Pays-Bas] ; S. Stevens [Pays-Bas] ; M. Vervoort [Pays-Bas] ; M. Hashimoto [États-Unis] ; E. Masliah [États-Unis] ; P. Chan ; D. A. Di Monte [États-Unis] ; J. W. Langston [États-Unis] ; G. Petzinger [États-Unis] ; H. Hoogendoorn [Canada] ; D. G. Munoz [Canada, Espagne] | Absence of elevated anti-α-synuclein and anti-EBV latent membrane protein antibodies in PD |
| 000A45 |
Rubia P. Meshack [Canada] ; Kathleen E. Norman [Canada] | A randomized controlled trial of the effects of weights on amplitude and frequency of postural hand tremor in people with Parkinson's disease |
| 000A46 |
Ravikant S. Palur [Canada] ; Caglar Berk ; Michael Schulzer ; Christopher R. Honey | A metaanalysis comparing the results of pallidotomy performed using microelectrode recording or macroelectrode stimulation |
| 000A47 |
Jean-Pierre Melun [Canada] ; Louise M. Morin [Canada] ; J. Gerard Muise [Canada] ; Marc Desrosiers [Canada] | Color vision deficiencies in Gilles de la Tourette syndrome |
| 000A48 |
| Parkinson's disease |
| 000A49 |
J. Thomas Hutton [États-Unis] ; Jerry L. Morris [États-Unis] | Vision in Parkinson's disease |
| 000A51 |
J. Thomas Hutton [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Jorge L. Juncos [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Peter A. Lewitt [États-Unis] ; Ali Samii [Canada] ; Joseph K. C. Tsui [Canada] ; Donald B. Calne [Canada] ; Cheryl H. Waters [États-Unis] ; Vincent P. Calabrese [États-Unis] ; James P. Bennett [États-Unis] ; Richard Barrett [États-Unis] ; Jerry L. Morris [États-Unis] | Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N-0923 TDS: A double-blind, placebo-controlled study |
| 000A52 |
Alain Dagher [Royaume-Uni, Canada] ; Adrian M. Owen [Royaume-Uni] ; Henning Boecker [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | The role of the striatum and hippocampus in planning : A PET activation study in Parkinson's disease |
| 000A53 |
Ali H. Rajput [Canada] | The protective role of levodopa in the human substantia nigra |
| 000A54 |
Kurt A. Jellinger [Autriche] | The pathology of Parkinson's disease |
| 000A55 |
Serge Przedborski [États-Unis] ; Miquel Vila | The last decade in Parkinson's disease research: Basic sciences |
| 000A56 |
Stephen A. Marion [Canada] | The epidemiology of Parkinson's disease: Current issues |
| 000A57 |
Andrzej Friedman [Pologne] ; Jolanta Galazka-Friedman [Pologne] | The current state of free radicals in Parkinson's disease: Nigral iron as a trigger of oxidative stress |
| 000A58 |
Lauri V. Laitinen [Suède] | Surgical treatment for Parkinson's disease over the last decade |
| 000A59 |
C. Warren Olanow [États-Unis] ; Mitchell F. Brin [États-Unis] | Surgical therapies for Parkinson's disease: A physician's perspective |
| 000A61 |
Thomas N. Chase [États-Unis] ; Spiridon Konitsiotis [États-Unis] ; Justin D. Oh [États-Unis] | Striatal molecular mechanisms and motor dysfunction in Parkinson's disease |
| 000A62 |
Fabrizio Stocchi [Italie] ; Laura Vacca [Italie] ; Marcella Valente [Italie] ; Stefano Ruggieri [Italie] | Sleep disorders in Parkinson's disease |
| 000A63 |
Rosemary Basson [Canada] | Sex and idiopathic Parkinson's disease |
| 000A64 |
Vijay Dhawan [États-Unis] ; David Eidelberg [États-Unis] | SPECT imaging in Parkinson's disease |
| 000A66 |
Erik Ch. Wolters [Pays-Bas] | Psychiatric complications in the treatment of Parkinson's disease |
| 000A67 |
P. Ashby [Canada] ; G. Paradiso [Canada] ; J. A. Saint-Cyr [Canada] ; R. Chen [Canada] ; A. E. Lang [Canada] ; A. M. Lozano [Canada] | Potentials recorded at the scalp by stimulation near the human subthalamic nucleus |
| 000A68 |
Andreas Hartmann [France] ; Etienne C. Hirsch [France] | Parkinson's disease: The apoptosis hypothesis revisited |
| 000A69 |
Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Pallidotomy for Parkinson's disease |
| 000A70 |
Ahmed Alkhani [Canada] ; Andres M. Lozano [Canada] | Pallidotomy for Parkinson disease : a review of contemporary literature |
| 000A71 |
Doris J. Doudet [Canada] | PET studies in the MPTP model of Parkinson's disease |
| 000A72 |
Amos D. Korczyn [Israël] | Neuropsychiatric manifestations in Parkinson's disease |
| 000A73 |
A. Jon Stoessl [Canada] | Neurochemical and neuroreceptor imaging with PET in Parkinson's disease |
| 000A74 |
Thomas B. Freeman [États-Unis] ; Allison Willing [États-Unis] ; Tanya Zigova [États-Unis] ; Paul R. Sanberg [États-Unis] ; Robert A. Hauser [États-Unis] | Neural transplantation in Parkinson's disease |
| 000A75 |
Peter Riederer [Allemagne] ; Heinz Reichmann [Allemagne] ; Bernd Janetzky [Allemagne] ; Jeswinder Sian [Allemagne] ; Klaus-Peter Lesch [Allemagne] ; Klaus W. Lange [Allemagne] ; K. L. Double [Allemagne] ; Toshiharu Nagatsu [Japon] ; Manfred Gerlach [Allemagne] | Neural degeneration in Parkinson's disease |
| 000A76 |
M. Fukuda [États-Unis] ; M. J. Mentis [États-Unis] ; Y. Ma [États-Unis] ; V. Dhawan [États-Unis] ; A. Antonini [États-Unis] ; A. E. Lang [Canada] ; A. M. Lozano [Canada] ; J. Hammerstad [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis] ; J. R. Moeller [États-Unis] ; D. Eidelberg [États-Unis] | Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: A pet study of resting-state glucose metabolism |
| 000A77 |
Edith V. Sullivan [États-Unis] ; Paula K. Shear [États-Unis] ; Maria Stein [États-Unis] ; Rosemary Fama [États-Unis] ; Deborah A. Cahn-Weiner [États-Unis] ; Robert B. Zipursky [Canada] ; Adolf Pfefferbaum [États-Unis] | Motor sequencing deficits in schizophrenia: a comparison with Parkinson's disease |
| 000A78 |
Doris J. Doudet [Canada] | Monitoring disease progression in Parkinson's disease |
| 000A79 |
Thomas Gasser [Allemagne] | Molecular genetics of Parkinson's disease |
| 000A80 |
Richard Camicioli [États-Unis, Canada] ; Eric Lea [États-Unis] ; John G. Nutt [États-Unis] ; Gary Sexton [États-Unis] ; Barry S. Oken [États-Unis] | Methylphenidate increases the motor effects of L-Dopa in Parkinson's disease: A pilot study |
| 000A81 |
K. Yasojima [Canada] ; W. W. Tourtellotte [États-Unis] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy |
| 000A82 |
W. R. Wayne Martin [Canada] | Magnetic resonance imaging and spectroscopy in Parkinson's disease |
| 000A85 |
Evian Gordon [Australie] | Integrative psychophysiology |
| 000A87 |
M. Guttman [Canada] ; D. Stewart [Canada] ; D. Hussey [Canada] ; A. Wilson [Canada] ; S. Houle [Canada] ; S. Kish [Canada] | Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD |
| 000A88 |
Patrick L. Mcgeer [Canada] ; Koji Yasojima [Canada] ; Edith G. Mcgeer [Canada] | Inflammation in Parkinson's disease |
| 000A89 |
Mahyar Etminan [Canada] ; Ali Samii [États-Unis] ; Bahi Takkouche [Espagne] ; Paula A. Rochon [Canada] | Increased risk of somnolence with the new dopamine agonists in Patients with Parkinson's disease: A meta-analysis of randomised controlled trials |
| 000A90 |
Hitoshi Shinotoh [Japon] ; Hiroki Namba [Japon] ; Mika Yamaguchi [Japon] ; Kiyoshi Fukushi [Japon] ; Shin-Ichiro Nagatsuka [Japon] ; Masaomi Iyo [Japon] ; Masato Asahina [Japon] ; Takamichi Hattori [Japon] ; Shuji Tanada [Japon] ; Toshiaki Irie [Japon] | In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy |
| 000A92 |
Ole Isacson [États-Unis] ; Craig Van Horne [États-Unis] ; James M. Schumacher [États-Unis] ; Anna-Liisa Brownell [États-Unis] | Improved surgical cell therapy in Parkinson's disease: Physiological basis and new transplantation methodology |
| 000A93 |
Robert Chen [Canada] ; SAMEER KUMAR [Canada] ; Rami R. Garg [Canada] ; Anthony E. Lang [Canada] | Impairment of motor cortex activation and deactivation in Parkinson's disease |
| 000A94 |
Caterina Breitenstein [Allemagne, États-Unis, Canada] ; Diana Van Lancker [États-Unis] ; Irene Daum [Allemagne] ; Cheryl H. Waters [États-Unis] | Impaired perception of vocal emotions in Parkinson's disease : Influence of speech time processing and executive functioning |
| 000A95 |
Kirk A. Frey [États-Unis] ; Robert A. Koeppe ; Michael R. Kilbourn | Imaging the vesicular monoamine transporter |
| 000A96 |
Michael H. Gollob [États-Unis] ; Martin S. Green [Canada] ; Anthony S.-L. Tang [Canada] ; Tanya Gollob [États-Unis] ; Akihiko Karibe [États-Unis] ; Al-Sayegh Hassan [Canada] ; Ferhaan Ahmad [États-Unis] ; Ryan Lozado [États-Unis] ; Gopi Shah [États-Unis] ; Lameh Fananapazir [Canada, États-Unis] ; Linda L. Bachinski [États-Unis] ; Robert Roberts [États-Unis] | Identification of A gene responsible for familial wolff-parkinson-white syndrome |
| 000A97 |
Kevin St. P. Mcnaught [Royaume-Uni] ; Moonhee Lee [Royaume-Uni] ; Dong-Hoon Hyun [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Glial cells and abnormal protein handling in the pathogenesis of Parkinson's disease |
| 000A98 |
A. L. Destefano [États-Unis] ; L. I. Golbe [États-Unis] ; M. H. Mark [États-Unis] ; A. M. Lazzarini [États-Unis] ; N. E. Maher [États-Unis] ; M. Saint-Hilaire [États-Unis] ; R. G. Feldman [États-Unis] ; M. Guttman [États-Unis] ; R. L. Watts [États-Unis] ; O. Suchowersky [Canada] ; A. L. Lafontaine [Canada] ; N. Labelle [Canada] ; M. F. Lew [États-Unis] ; C. H. Waters [États-Unis] ; J. H. Growdon [États-Unis] ; C. Singer [États-Unis] ; L. J. Currie [États-Unis] ; G. F. Wooten [États-Unis] ; P. Vieregge [Allemagne] ; P. P. Pramstaller [Italie] ; C. Klein [Allemagne] ; J. P. Hubble [États-Unis] ; M. Stacy [États-Unis] ; E. Montgomery [États-Unis] ; M. E. Macdonald [États-Unis] ; J. F. Gusella [États-Unis] ; R. H. Myers [États-Unis] | Genome-wide scan for Parkinson's disease: The genePD Study |
| 000A99 |
Nir Giladi [Israël] | Gait disturbances in advanced stages of Parkinson's disease |
| 000B00 |
David B. Ramsden [Royaume-Uni] ; Richard B. Parsons [Royaume-Uni] ; Shu-Leong Ho [Hong Kong] ; TAO XIE [États-Unis] ; Rosemary Hope Waring [Royaume-Uni] ; Adrian Charles Williams [Hong Kong] | Further studies in xenobiotic metabolism and Parkinson's disease |
| 000B01 |
Masafumi Fukuda [États-Unis] ; Marc Mentis [États-Unis] ; Maria Felice Ghilardi [États-Unis] ; Vijay Dhawan [États-Unis] ; Angelo Antonini [États-Unis] ; John Hammerstad [États-Unis] ; Andres M. Lozano [Canada] ; Anthony Lang [Canada] ; Kelly Lyons [États-Unis] ; William Koller [États-Unis] ; Claude Ghez [États-Unis] ; David Eidelberg [États-Unis] | Functional correlates of pallidal stimulation for Parkinson's Disease |
| 000B02 |
John Woulfe [Canada] ; Andrew Kertesz [Canada] ; David G. Munoz [Canada, Espagne] | Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions |
| 000B03 |
John G. Nutt [États-Unis] | Fluctuations in response to treatment for Parkinson's disease |
| 000B04 |
Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon] ; Tohru Kitada [Japon] ; Hiroto Matsumine [Japon] ; Hideo Mori [Japon] ; Hideki Shimura [Japon] ; Shinichiro Kubo [Japon] ; Hirokazu Kobayashi [Japon] ; Shuichi Asakawa [Japon] ; Shinsei Minoshima [Japon] ; Nobuyoshi Shimizu [Japon] | Familial Parkinson's disease: α-Synuclein and parkin |
| 000B05 |
Zbigniew K. Wszolek [États-Unis] ; Ryan J. Uitti [États-Unis] ; Katerina Markopoulou [États-Unis] | Familial Parkinson's disease and related conditions: Clinical genetics |
| 000B06 |
André Parent [Canada] ; Martine Cossette [Canada] | Extrastriatal dopamine and Parkinson's disease |
| 000B07 |
Raul De La Fuente-Fernandez [Canada] ; Thomas J. Ruth [Canada] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's disease |
| 000B10 |
Poornima K. Tekumalla [États-Unis] ; Frédéric Calon [Canada] ; Zia Rahman [États-Unis] ; Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Therese Di Paolo [Canada] ; Paul J. Bedard [Canada] ; Eric J. Nestler [États-Unis] | Elevated levels of ΔFosB and RGS9 in striatum in Parkinson's disease |
| 000B11 |
B. M. Ross [Canada] ; N. Mamalias [Canada] ; A. Moszczynska [Canada] ; A. H. Rajput [Canada] ; S. J. Kish [Canada] | Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease |
| 000B15 |
Moussa B. H. Youdim [Israël] ; Edna Grünblatt [Israël] ; Yona Levites-Royak [Israël] ; Silvia Mandel [Israël] | Drugs to prevent cell death in Parkinson's disease: Neuroprotection against oxidative stress and inflammatory gene expression |
| 000B16 |
Oleh Hornykiewicz [Autriche] | Dopamine and Parkinson's disease: A personal view of the past, the present, and the future |
| 000B17 |
Olivier Rascol [France] ; Joaquim J. Ferreira [Portugal] ; Claire Thalamas [France] ; Monique Galitsky [France] ; Jean-Louis Montastruc [France] | Dopamine agonists: Their role in the management of Parkinson's disease |
| 000B19 |
Robert Jr Laforce [Canada] ; Julien Doyon [Canada] | Distinct contribution of the striatum and cerebellum to motor learning |
| 000B21 |
Wolfgang H. Oertel [Allemagne] ; Günter U. Höglinger [Allemagne] ; Tommaso Caraceni [Italie] ; F. Girotti [Italie] ; Tobias Eichhorn [Allemagne] ; Annika E. Spottke [Allemagne] ; Jürgen C. Krieg [Allemagne] ; Werner Poewe [Autriche] | Depression in Parkinson's disease: An update |
| 000B24 |
Alim-Louis Benabid [France] ; Adnan Koudsie [France] ; Abdelhamid Benazzouz [France] ; Brigitte Piallat [France] ; Paul Krack [Allemagne] ; Patricia Limousin-Dowsey [Royaume-Uni] ; Jean Francois Lebas [France] ; Pierre Pollak [France] | Deep brain stimulation for Parkinson's disease |
| 000B25 |
Hiroshi Ichinose [Japon] ; Takahiro Suzuki [Japon] ; Hidehito Inagaki [Japon] ; Tamae Ohye [Japon] ; Toshiharu Nagatsu [Japon] | DOPA-responsive dystonia: From causative gene to molecular mechanism |
| 000B26 |
Oksana Suchowersky [États-Unis, Canada] ; Peter Bailey ; E. Pourcher ; Lynne Bulger ; Giovanni Facciponte | Comparison of two dosages of tolcapone added to levodopa in nonfluctuating patients with PD |
| 000B27 |
Michael Schulzer [Canada] | Common pitfalls in the interpretation of statistical tests in the measurement of quality of life in Parkinson's disease |
| 000B28 |
Lüder Deecke [Autriche] | Clinical neurophysiology of Parkinson's disease: Bereitschaftspotential and contingent negative variation |
| 000B29 |
David J. Brooks [Royaume-Uni] | Cerebral blood flow activation studies in Parkinson's disease |
| 000B30 |
A. H. V. Schapira [Royaume-Uni] | Causes of neuronal death in Parkinson's disease |
| 000B31 |
Heikki Ter V Inen [Finlande] ; Urpo Rinne [Finlande] ; Ariel Gordin [Finlande] | Catechol-O-methyltransferase inhibitors in Parkinson's disease |
| 000B32 |
Raul De La Fuente-Fernandez [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease : PET evidence of increased dopamine turnover |
| 000B33 |
Marco Scarselli [Italie] ; Marianna Armogida [Italie] ; Carla Pardini [Italie] ; Serena Chiacchio [Italie] ; Giovanni U. Corsini [Italie] | Apomorphine: A novel effect for an old compound |
| 000B34 |
Raul De La Fuente-Fernandez [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; James E. Holden [États-Unis] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Apomorphine-induced changes in synaptic dopamine levels : Positron emission tomography evidence for presynaptic inhibition |
| 000B35 |
Lana Depatie [Canada] ; Samarthji Lal [Canada] | Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma? |
| 000B37 |
Kjell Fuxe [Suède] ; Ingrid Strömberg [Suède] ; Patrizia Popoli [Italie] ; Roberto Rimondini-Giorgini [Suède] ; Maria Torvinen [Suède] ; Sven O. Ögren [Suède] ; Rafael Franco [Espagne] ; Luigi F. Agnati [Italie] ; Sergi Ferre [Suède] | Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum |
| 000B38 |
Vesna Sossi [États-Unis] ; Doris J. Doudet [Canada] ; James E. Holden [États-Unis] | A reversible tracer analysis approach to the study of effective dopamine turnover |
| 000B39 |
Mitsuo Takahashi [Japon] ; Tatsuo Yamada [Japon] | A possible role of influenza A virus infection for Parkinson's disease |
| 000B40 |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; LEE CYN ANG [Canada] ; Jcm Zijlmans [Royaume-Uni] ; G. K. Wenning [Autriche] | 69-year-old man with gait disturbance and parkinsonism |
| 000B43 |
R. Kumar [Canada] ; A. E. Lang [Canada] ; M. C. Rodriguez-Oroz [Espagne] ; A. M. Lozano [Canada] ; P. Limousin [France] ; P. Pollak [France] ; A. L. Benabid [France] ; J. Guridi [Espagne] ; E. Ramos [Espagne] ; C. Van Der Linden [Belgique] ; A. Vandewalle [Belgique] ; J. Caemaert [Belgique] ; E. Lannoo [Belgique] ; D. Van Den Abbeele [Belgique] ; G. Vingerhoets [Belgique] ; M. Wolters [Belgique] ; J. A. Obeso [Espagne] | eep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease |
| 000B45 |
H. Poizner [États-Unis] ; A. G. Feldman [Canada] ; M. F. Levin [Canada] ; M. B. Berkinblit [États-Unis, Russie] ; W. A. Hening [États-Unis] ; A. Patel [États-Unis] ; S. V. Adamovich [États-Unis, Russie] | The timing of arm-trunk coordination is deficient and vision-dependent in Parkinson's patients during reaching movements |
| 000B46 |
D. J. Chong [Canada] ; O. Suchowersky [Canada] ; C. Szumlanski [États-Unis] ; R. M. Weinshilboum [États-Unis] ; R. Brant [Canada] ; N. R. C. Campbell [Canada] | The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's Disease |
| 000B47 |
P. A. Pahapill [Canada] ; A. M. Lozano [Canada] | The pedunculopontine nucleus and Parkinson's disease |
| 000B48 |
Joseph Jankovic [États-Unis] ; A. H. Rajput [Canada] ; M. P. Mcdermott [États-Unis] ; D. P. Perl [États-Unis] | The evolution of diagnosis in early Parkinson Disease |
| 000B52 |
J. Guridi [Espagne] ; M. C. Rodriguez-Oroz [Espagne] ; A. M. Lozano [Canada] ; E. Moro [Italie] ; A. Albanese [Italie] ; B. Nuttin [Belgique] ; J. Gybels [Belgique] ; E. Ramos [Espagne] ; J. A. Obeso [Espagne] | Targeting the basal ganglia for deep brain stimulation in Parkinson's disease |
| 000B54 |
A. E. Lang [Canada] ; LANGSTON ; RASCOL ; BROTCHIE ; BENABID ; MELAMED ; BONUCELLI ; OLANOW ; OBESO ; GIMENEZ-ROLDAN ; RAJPUT ; FAHN ; NUTT ; BROOKS ; CHASE | Surgery for levodopa-induced dyskinesias. Discussion |
| 000B55 |
A. E. Lang [Canada] | Surgery for Parkinson disease : A critical evaluation of the state of the art |
| 000B58 |
Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique] | Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial |
| 000B59 |
W. J. Lombardi [États-Unis, Canada] ; R. E. Gross [États-Unis, Canada] ; L. L. Trepanier [Canada] ; A. E. Lang [Canada] ; A. M. Lozano [Canada] ; J. A. Saint-Cyr [Canada] | Relationship of lesion location to cognitive outcome following microelectrode-guided pallidotomy for Parkinson's disease: Support for the existence of cognitive circuits in the human pallidum |
| 000B63 |
Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada] | R-(-)-deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition |
| 000B65 |
M. Filion [Canada] ; OBESO ; BENABID ; OLANOW ; LANG ; HIRSCH ; NUTT | Physiologic basis of dyskinesia. Discussion |
| 000B66 |
B. J. Snow [Canada] ; F. J. G. Vingerhoets [Canada] ; J. W. Langston [États-Unis] ; J. W. Tetrud [États-Unis] ; V. Sossi [Canada] ; D. B. Calne [Canada] | Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism |
| 000B67 |
Duong P. Huynh [États-Unis] ; Daniel R. Scoles [États-Unis] ; Trang H. Ho [États-Unis] ; Marc R. Del Bigio [Canada] ; Stefan-M. Pulst [États-Unis] | Parkin is associated with actin filaments in neuronal and nonneural cells |
| 000B70 |
P. E. Radau [États-Unis, Canada, Allemagne] ; R. Linke ; P. J. Slomka ; K. Tatsch | Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism |
| 000B72 |
P. Seeman [Canada] ; D. Nam [Canada] ; C. Ulpian [Canada] ; I. S. C. Liu [Canada] ; T. Tallerico [Canada] | New dopamine receptor, D2Longer, with unique TG splice site, in human brain |
| 000B73 |
L. L. Trepanier [Canada] ; R. Kumar [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] ; J. A. Saint-Cyr [Canada] | Neuropsychological outcome of GPI pallidotomy and GPI or STN deep brain stimulation in Parkinson's disease |
| 000B74 |
Jean A. Saint-Cyr [Canada] ; Lisa L. Trepanier [Canada] ; Rajeev Kumar [États-Unis] ; Andres M. Lozano [Canada] ; A. E. Lang [Canada] | Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease |
| 000B75 |
Jean A. Saint-Cyr [Canada] ; Lisa L. Trepanier [Canada] | Neuropsychologic assessment of patients for movement disorder surgery |
| 000B76 |
P. Ashby [Canada] ; J. C. Rothwell [Royaume-Uni] | Neurophysiologic aspects of deep brain stimulation |
| 000B77 |
A. M. Lozano [Canada] ; A. E. Lang [Canada] ; R. Levy [Canada] ; W. Hutchison [Canada] ; J. Dostrovsky [Canada] | Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine |
| 000B80 |
J. Woulfe [Canada] ; H. Hoogendoorn [Canada] ; M. Tarnopolsky [Canada] ; D. G. Munoz [Canada, Espagne] | Monoclonal antibodies against Epstein-Barr virus cross-react with α-synuclein in human brain |
| 000B83 |
J. Fine [Canada] ; J. Duff [Canada] ; R. Chen [Canada] ; W. Hutchison [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] | Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease |
| 000B84 |
P. K. Pal [Canada] ; A. Samii [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; I. M. Turnbull [Canada] ; D. B. Calne [Canada] | Long term outcome of unilateral pallidotomy : Follow up of 15 patients for 3 years |
| 000B85 |
Ida Tonolli [France] ; Roselyne Aurenty [France] ; Robert George Lee [France, Canada] ; Francois Viallet [France] ; Jean Massion [France] | Lateral leg raising in patients with Parkinson's disease : Influence of equilibrium constraint |
| 000B88 |
C. S. Lee [Canada] ; A. Samii [Canada] ; V. Sossi [Canada] ; T. J. Ruth [Canada] ; M. Schulzer [Canada] ; J. E. Holden [États-Unis] ; J. Wudel [Canada] ; P. K. Pal [Canada] ; R. De La Fuente-Fernandez [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada] | In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease |
| 000B90 |
J. E. Robinson [Canada] ; V. I. Morin [Canada] ; M. J. Douglas [Canada] ; R. D. Wilson [Canada] | Familial hypokalemic periodic paralysis and Wolff-Parkinson-White syndrome in pregnancy |
| 000B91 |
C. Duval [Canada] ; M. Panisset [Canada] ; G. Bertrand [Canada] ; A. F. Sadikot [Canada] | Evidence that ventrolateral thalamotomy may eliminate the supraspinal component of both pathological and physiological tremors |
| 000B92 |
R. De La Fuente-Fernandez [Canada] ; P. K. Pal [Canada] ; F. J. G. Vingerhoets [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. K. Mak [Canada] ; T. J. Ruth [Canada] ; B. J. Snow [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada] | Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations |
| 000B93 |
I. Mendez [Canada] ; A. Dagher ; M. Hong ; A. Hebb ; P. Gaudet ; A. Law ; S. Weerasinghe ; D. King ; J. Desrosiers ; S. Darvesh ; T. Acorn ; H. Robertson | Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease : Report of two cases and technical considerations |
| 000B96 |
M. Cyr [Canada] ; F. Calon [Canada] ; M. Morissette [Canada] ; M. Grandbois [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Drugs with estrogen-like potency and brain activity : Potential therapeutic application for the CNS |
| 000B98 |
Lucie Godbout [Canada] ; Julien Doyon [Canada] | Defective representation of knowledge in Parkinson's disease: Evidence from a script-production task |
| 000C00 |
D. V. Exner [Canada] ; L. B. Mitchell [Canada] ; D. G. Wyse [Canada] ; R. S. Sheldon [Canada] ; A. M. Gillis [Canada] ; P. Cassidy [Canada] ; H. J. Duff [Canada] | Conduction time oscillations precede the spontaneous termination of human atrioventricular reciprocating tachycardia |
| 000C01 |
J. F. Marsden [Royaume-Uni] ; P. Ashby [Canada] ; P. Limousin-Dowsey [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; P. Brown [Royaume-Uni] | Coherence between cerebellar thalamus, cortex and muscle in man: Cerebellar thalamus interactions |
| 000C02 |
C. S. Kubu [Canada] ; G. M. Grace ; A. G. Parrent | Cognitive outcome following pallidotomy : the influence of side of surgery and age of patient at disease onset |
| 000C09 |
C. R. Honey [Canada] ; R. A. Nugent [Canada] | A prospective randomized comparison of CT and MRI pre-operative localization for pallidotomy |
| 000C11 |
O. Monchi [Canada] ; J. G. Taylor [Royaume-Uni] ; A. Dagher [Canada] | A neural model of working memory processes in normal subjects, Parkinson's disease and schizophrenia for fMRI design and predictions |
| 000C12 |
O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; P. P. De Deyn [Belgique] ; C. E. Clarke [Royaume-Uni] ; A. E. Lang [Canada] | A five-year study of the incidence of dyskinesia in patients with early parkinson's disease who were treated with ropinirole or levodopa |
| 000C14 |
H. Barthel [Allemagne] ; U. Müller [Allemagne] ; T. W Chter [Allemagne] ; P. Slomka [Canada] ; C. Dannenberg [Allemagne] ; T. Murai [Allemagne] ; T. Kahn [Allemagne] ; P. Georgi [Allemagne] | Multimodale SPECT- und MRT-Bilddatenanalyse zur Verbesserung der Diagnostik des idiopathischen Parkinson-Syndroms : Radiologische Diagnostik und Nuklearmedizin |
| 000C16 |
R. E. Gross [Canada] ; W. J. Lombardi ; W. D. Hutchison ; S. Narula ; J. A. Saint-Cyr ; J. O. Dostrovsky ; R. R. Tasker ; A. E. Lang ; A. M. Lozano | Variability in lesion location after microelectrode-guided pallidotomy for Parkinson's disease : anatomical, physiological, and technical factors that determine lesion distribution |
| 000C17 |
C. R. Honey [Canada] ; A. J. Stoessl [Canada] ; J. K. C. Tsui [Canada] ; M. Schulzer [Canada] ; D. B. Calne [Canada] | Unilateral pallidotomy for reduction of parkinsonian pain |
| 000C18 |
K. E. Norman [Canada] ; R. Edwards [Canada] ; C. Duval [Canada] ; S. Patenaude [Canada] ; A. Beuter [Canada] | Two-dimensional geometry and electromyography of spontaneous and imitated Parkinsonian wrist tremor |
| 000C19 |
D. A. Grimes [Canada] ; A. E. Lang | Treatment of early Parkinson's disease |
| 000C20 |
K. E. Norman [Canada] ; R. Edwards [Canada] ; A. Beuter [Canada] | The measurement of tremor using a velocity transducer : Comparison to simultaneous recordings using transducers of displacement, acceleration and muscle activity |
| 000C22 |
V. Fraïle [Canada] ; H. Cohen [Canada] | Temporal control of voicing in Parkinson's disease and tardive dyskinesia speech |
| 000C25 |
M. D. Sharpe [Canada] ; D. J. Cuillerier [Canada] ; J. K. Lee [Canada] ; M. Basta [Canada] ; A. D. Krahn [Canada] ; G. J. Klein [Canada] ; R. Yee [Canada] | Sevoflurane has no effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolan anesthesia |
| 000C26 |
M. Grossman [États-Unis] | Sentence processing in Parkinson's disease |
| 000C27 |
M. Ichise [Canada] ; Y. J. Kim [Canada] ; J. R. Ballinger [Canada] ; D. Vines [Canada] ; S. S. Erami [Canada] ; F. Tanaka [Canada] ; A. E. Lang [Canada] | SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD |
| 000C28 |
D. E. Hobson [Canada] ; E. Pourcher [Canada] ; W. R. W. Martin [Canada] | Ropinirole and pramipexole, the new agonists |
| 000C29 |
R. E. Gross [Canada] ; W. J. Lombardi [Canada] ; A. E. Lang [Canada] ; J. Duff [Canada] ; W. D. Hutchison [Canada] ; J. A. Saint-Cyr [Canada] ; R. R. Tasker [Canada] ; A. M. Lozano [Canada] | Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's disease |
| 000C30 |
A. Samii [Canada] ; I. M. Turnbull [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; D. B. Calne [Canada] | Reassessment of unilateral pallidotomy in Parkinson's disease: A 2-year follow-up study |
| 000C31 |
P. J. Blanchet [Canada] | Rationale for use of dopamine agonists in Parkinson's disease : Review of ergot derivatives |
| 000C32 |
Nicolaas Paul L. G. Verhoeff [Canada] | Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders |
| 000C34 |
A. Beuter [Canada] ; A. De Geoffroy [Canada] ; R. Edwards [Canada] | Quantitative analysis of rapid pointing movements in Cree subjects exposed to mercury and in subjects with neurological deficits |
| 000C35 |
J. B. A. Habraken [Pays-Bas, Canada] ; J. Booij ; P. Slomka ; E. B. Sokole ; E. A. Van Royen | Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm |
| 000C36 |
A. E. Lang [Canada] ; J. Duff [Canada] ; J. A. Saint-Cyr [Canada] ; L. Trepanier [Canada] ; R. E. Gross [Canada] ; W. Lombardi [Canada] ; E. Montgomery [États-Unis] ; W. Hutchinson [Canada] ; A. M. Lozano [Canada] | Posteroventral medial pallidotomy in Parkinson's disease |
| 000C38 |
M. Guttman [Canada] ; O. Suchowersky [Canada] | Parkinson's disease management : Towards a new paradigm |
| 000C39 |
D. B. King [Canada] | Parkinson's disease : Levodopa complications |
| 000C40 |
A. Samii [Canada] ; K. Markopoulou [États-Unis] ; Z. K. Wszolek [États-Unis] ; V. Sossi [Canada] ; T. Dobko [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada] | PET studies of parkinsonism associated with mutation in the α-synuclein gene |
| 000C41 |
C. Schwab [Canada] ; M. Schulzer [Canada] ; J. C. Steele ; P. L. Mcgeer [Canada] | On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam |
| 000C42 |
J. K. C. Tsui [Canada] ; D. B. Calne [Canada] ; YUE WANG [Canada] ; M. Schulzer [Canada] ; S. A. Marion [Canada] | Occupational risk factors in Parkinson's disease |
| 000C43 |
C. Honey [Canada] ; R. E. Gross [Canada] ; A. M. Lozano [Canada] | New developments in the surgery for Parkinson's disease |
| 000C44 |
P. Ashby [Canada] ; Y. J. Kim [Canada] ; R. Kumar [Canada] ; A. E. Lang [Canada] ; A. M. Lozano [Canada] | Neurophysiological effects of stimulation through electrodes in the human subthalamic nucleus |
| 000C47 |
T. Mendis [Canada] ; O. Suchowersky [Canada] ; A. Lang [Canada] ; S. Gauthier [Canada] | Management of Parkinson's disease : A review of current and new therapies |
| 000C49 |
G. G. Brown [États-Unis, Canada] ; C. Mcdonald [Canada] ; K. Spicer [États-Unis] | Lexical priming on Neely's (1977) paradigm in Parkinson's disease : Where do we stand? |
| 000C51 |
R. Edwards [Canada] ; A. Beuter [Canada] | Indexes for identification of abnormal tremor using computer tremor evaluation systems |
| 000C54 |
M. Ichise [Canada] ; Y. J. Kim ; S. S. Erami ; J. R. Ballinger ; D. Vines ; F. Tanaka ; A. E. Lang | Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-β-CIT SPECT data |
| 000C58 |
A. J. Stoessl [Canada] | Etiology of Parkinson's disease |
| 000C61 |
B. E. Burbridge [Canada] ; J. K. Wallace [Canada] ; A. Rajput [Canada] ; L. Mcculloch [Canada] | Doppler ultrasonographic examination of the leg veins of patients with Parkinson disease |
| 000C63 |
A. J. Stoessl [Canada] ; J. Rivest [Canada] | Differential diagnosis of Parkinsonism |
| 000C67 |
R. Kumar [Canada] ; A. M. Lozano [Canada] ; E. Sime [Canada] ; E. Halket [Canada] ; A. E. Lang [Canada] | Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation |
| 000C68 |
I. Litvan [États-Unis] ; D. A. Grimes [Canada] ; A. E. Lang [Canada] ; Joseph Jankovic [États-Unis] ; A. Mckee [États-Unis] ; M. Verny [France] ; K. Jellinger [Autriche] ; K. R. Chaudhuri [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni] | Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration |
| 000C70 |
J. Rivest [Canada] ; C. L. Barclay [Canada] ; O. Suchowersky [Canada] | COMT inhibitors in Parkinson's disease |
| 000C71 |
M. Lauk [États-Unis, Allemagne] ; C. C. Chow [États-Unis] ; L. A. Lipsitz [États-Unis] ; S. L. Mitchell [États-Unis, Canada] ; J. J. Collins [États-Unis] | Assessing muscle stiffness from quiet stance in Parkinson's disease |
| 000C72 |
J. Kegl [Canada] ; H. Cohen [États-Unis] ; H. Poizner [États-Unis] | Articulatory consequences of Parkinson's disease : Perspectives from two modalities |
| 000C74 |
A. Beuter [Canada] ; A. De Geoffroy [Canada] ; R. Edwards [Canada] | Analysis of rapid alternating movements in Cree subjects exposed to methylmercury and in subjects with neurological deficits |
| 000C75 |
M. A. Bedard [Canada] ; B. Pillon [France] ; B. Dubois [France] ; N. Duchesne [Canada] ; H. Masson [Canada] ; Yves Agid [France] | Acute and long-term administration of anticholinergics in Parkinson's disease : Specific effects on the subcortico-frontal syndrome |
| 000C76 |
V. Radhakrishnan [Canada] ; J. Tsoukatos [Canada] ; K. D. Davis [Canada] ; R. R. Tasker [Canada] ; A. M. Lozano [Canada] ; J. O. Dostrovsky [Canada] | A comparison of the burst activity of lateral thalamic neurons in chronic pain and non-pain patients |
| 000C77 |
T. L. Sourkes [Canada] | "Rational hope" in the early treatment of Parkinson's disease |
| 000C80 |
C. Schwab [Canada] ; P. L. Mcgeer [Canada] | Tubulin immunopositive structures resembling intracellular neurofibrillary tangles |
| 000C81 |
A. H. Rajput [Canada] ; W. Martin [Canada] ; M.-H. Saint-Hilaire [États-Unis] ; E. Dorflinger [États-Unis] ; S. Pedder [États-Unis] | Tolcapone improves motor function in parkinsonian patients with the "wearing-off" phenomenon : A double-blind, placebo-controlled, multicenter trial |
| 000C82 |
M. J. Majsak [États-Unis] ; T. Kaminski [États-Unis] ; A. M. Gentile [États-Unis] ; J. R. Flanagan [Canada] | The reaching movements of patients with Parkinson's disease under self-determined maximal speed and visually cued conditions |
| 000C86 |
R. Hren [États-Unis] ; G. Stroink [Canada] ; B. M. Horacek [Canada] | Spatial resolution of body surface potential maps and magnetic field maps : a simulation study applied to the identification of ventricular pre-excitation sites |
| 000C87 |
J. Doyon [Canada] ; R. Jr Laforce [Canada] ; G. Bouchard [Canada] ; D. Gaudreau [Canada] ; J. Roy [Canada, États-Unis] ; M. Poirier [États-Unis] ; P. J. Bedard [États-Unis] ; F. Bedard [Canada] ; J.-P. Bouchard [États-Unis] | Role of the striatum, cerebellum and frontal lobes in the automatization of a repeated visuomotor sequence of movements |
| 000C89 |
C. Schwab [Canada] ; J. C. Steele [États-Unis] ; P. L. Mcgeer [Canada] | Pyramidal neuron loss is matched by ghost tangle increase in Guam parkinsonism-dementia hippocampus |
| 000C90 |
A. Samii [Canada] ; S. R. Letwin [Canada] ; D. B. Calne [Canada] | Prospects for new drug treatment in idiopathic parkinsonism |
| 000C91 |
A. E. Lang [Canada] ; A. M. Lozano [Canada] | Parkinson's disease: First of two parts |
| 000C92 |
A. E. Lang [Canada] ; A. M. Lozano [Canada] | Parkinson's disease : Second of two parts |
| 000C94 |
R. Kumar [Canada] ; A. M. Lozano [Canada] ; E. Montgomery [États-Unis] ; A. E. Lang [Canada] | Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease |
| 000C95 |
N. Galvez-Jimenez [Canada] ; A. Lozano [Canada] ; R. Tasker [Canada] ; J. Duff [Canada] ; W. Hutchison [Canada] ; A. E. Lang [Canada] | Pallidal stimulation in Parkinson's disease patients with a prior unilateral pallidotomy |
| 000C98 |
H. M. Schipper [Canada] ; A. Liberman [Canada] ; E. G. Stopa [États-Unis] | Neural heme oxygenase-1 expression in idiopathic Parkinson's disease |
| 000C99 |
V. P. Calabrese [Canada] ; K. A. Lloyd [Canada] ; P. Brancazio [Canada] ; E. Cefali [États-Unis] ; P. Martin [États-Unis] ; J. Jr Wall [États-Unis] ; D. Sica [États-Unis] | N-0923, a novel soluble dopamine D2 agonist in the treatment of parkinsonism |
| 000D01 |
B. M. Ross [Canada] ; A. Moszczynska [Canada] ; J. Erlich [Canada] ; S. J. Kish [Canada] | Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra : Possible implications for Parkinson's disease |
| 000D03 |
J. H. Carter [États-Unis] ; B. J. Stewart [États-Unis] ; P. G. Archbold [États-Unis] ; I. Inoue [États-Unis] ; J. Jaglin [États-Unis] ; M. Lannon [États-Unis] ; E. Rost-Ruffner [États-Unis] ; M. Tennis [États-Unis] ; M. P. Mcdermott [États-Unis] ; D. Amyot [Canada] ; R. Barter [États-Unis] ; L. Cornelius [États-Unis] ; C. Demong [Canada] ; J. Dobson [États-Unis] ; J. Duff [Canada] ; J. Erickson [États-Unis] ; N. Gardiner [États-Unis] ; L. Gauger [États-Unis] ; P. Gray [Canada] ; B. Kanigan [Canada] ; B. Kiryluk [États-Unis] ; P. Lewis [États-Unis] ; K. Mistura [États-Unis] ; T. Malapira [États-Unis] ; M. Pay [États-Unis] ; C. Sheldon [États-Unis] ; L. Winfield [États-Unis] ; K. Wolfington-Shallow [États-Unis] ; K. Zoog [États-Unis] | Living with a person who has Parkinson's disease : The spouse's perspective by stage of disease |
| 000D04 |
C. F. Lippa [États-Unis] ; H. Fujiwara [Japon] ; D. M. A. Mann [Royaume-Uni] ; B. Giasson [États-Unis] ; M. Baba [Japon] ; M. L. Schmidt [États-Unis] ; L. E. Nee [États-Unis] ; B. O'Connell [États-Unis] ; D. A. Pollen [États-Unis] ; P. S. George-Hyslop [Canada] ; B. Ghetti [États-Unis] ; D. Nochlin [États-Unis] ; T. D. Bird [États-Unis] ; N. J. Cairns [Royaume-Uni] ; V. M.-Y. Lee [États-Unis] ; T. Iwatsubo [Japon] ; J. Q. Trojanowski [États-Unis] | Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes |
| 000D05 |
J. H. Growdon [États-Unis] ; K. Kieburtz [Canada] ; M. P. Mcdermott [Canada] ; M. Panisset [Canada] ; J. H. Friedman [États-Unis] | Levodopa improves motor function without impairing cognition in mild nondemented Parkinson's disease patients |
| 000D07 |
D. G. Walker [Canada] ; K. Terai [Canada] ; A. Matsuo [Canada] ; T. G. Beach [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases |
| 000D08 |
P. Ashby [Canada] ; A. Strafella [Canada] ; J. O. Dostrovsky [Canada] ; A. Lozano [Canada] ; A. E. Lang [Canada] | Immediate motor effects of stimulation through electrodes implanted in the human globus pallidus |
| 000D09 |
M. D. Muenter [États-Unis] ; L. S. Forno [États-Unis] ; O. Hornykiewicz [Autriche] ; S. J. Kish [Canada] ; D. M. Maraganore [États-Unis] ; R. J. Caselli [États-Unis] ; H. Okazaki [États-Unis] ; F. M. Jr Howard [États-Unis] ; B. J. Snow [Australie] ; D. B. Calne [Canada] | Hereditary form of parkinsonism-dementia |
| 000D12 |
P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada] | Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions |
| 000D14 |
J. H. Kordower [États-Unis] ; T. B. Freeman [États-Unis] ; E.-Y. Chen [États-Unis] ; E. J. Mufson [États-Unis] ; P. R. Sanberg [États-Unis] ; R. A. Hauser [États-Unis] ; B. Snow [Canada] ; C. W. Olanow [États-Unis] | Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease |
| 000D16 |
D. G. Walker [Canada] ; T. G. Beach [Canada] ; REN XU [États-Unis] ; J. Lile [États-Unis] ; K. D. Beck [États-Unis] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease |
| 000D19 |
R. Kumar [Canada] ; A. M. Lozano [Canada] ; Y. J. Kim [Canada] ; W. D. Hutchison [Canada] ; E. Sime [Canada] ; E. Halket [Canada] ; A. E. Lang [Canada] | Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson disease |
| 000D20 |
C. A. Shaw [Canada] ; J. S. Bains [Canada] | Did consumption of flour bleached by the agene process contribute to the incidence of neurological disease? |
| 000D21 |
R. R. Tasker [Canada] ; R. D. Penn [États-Unis] | Deep brain stimulation is preferable to thalamotomy for tremor suppression. Commentary |
| 000D23 |
M. Manford [Royaume-Uni] ; F. Andermann [Canada] | Complex visual hallucinations clinical and neurobiological insights |
| 000D25 |
M.-A. Bedard [Canada] ; F. El Massioui [France] ; C. Malapani [France] ; B. Dubois [France] ; B. Pillon [France] ; B. Renault [France] ; Yves Agid [France] | Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist |
| 000D27 |
D. P. Perl [États-Unis] ; C. W. Olanow [États-Unis] ; D. Calne [Canada] | Alzheimer's disease and Parkinson's disease : Distinct entities or extremes of a spectrum of neurodegeneration? |
| 000D31 |
A. Takeda [États-Unis, Japon] ; M. Mallory [États-Unis] ; M. Sundsmo [États-Unis] ; W. Honer [Canada] ; L. Hansen [États-Unis] ; E. Masliah [États-Unis] | Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders |
| 000D32 |
T. Gasser [Allemagne] ; B. Müller-Myhsok [Allemagne] ; Z. K. Wszolek [États-Unis] ; R. Oehlmann [Allemagne] ; D. B. Calne [Canada] ; V. Bonifati [Italie] ; B. Bereznai [Allemagne] ; E. Fabrizio [Italie] ; P. Vieregge [Allemagne] ; R. D. Horstmann [Allemagne] | A susceptibility locus for Parkinson's disease maps to chromosome 2p13 |
| 000D33 |
T. M. Peters [Canada] ; R. M. Comeau [Canada] ; R. Kasrai [Canada] ; P. S. Jean [Canada] ; D. Clonda [Canada] ; M. Sinasac [Canada] ; M. Audette [Canada] ; A. Fenster [Canada] | A comprehensive approach to image-guided surgery |
| 000D34 |
G. Le Dorze [Canada] ; J. Ryalls [États-Unis] ; C. Brassard [Canada] ; N. Boulanger [Canada] ; D. Ratte [Canada] | A comparison of the prosodic characteristics of the speech of people with Parkinson's disease and Friedreich's ataxia with neurologically normal speakers |
| 000D35 |
| Le traitement neurochirurgical de la maladie de Parkinson et autres mouvements anormaux |
| 000D36 |
| Thalamotomie |
| 000D37 |
| Stimulation thalamique |
| 000D38 |
| Stimulation subthalamique |
| 000D39 |
| Stimulation pallidale |
| 000D40 |
| Pallidotomie |
| 000D41 |
| Méthodes stéréotaxiques |
| 000D42 |
| Indications et choix de la cible |
| 000D43 |
O. Rascol [France] ; N. Fabre [France] ; U. Sabatini [Italie] | Imagerie fonctionnelle |
| 000D44 |
| Greffes |
| 000D45 |
A. Destee [France] | Données séméiologiques et principes actuels du traitement médical |
| 000D46 |
J. P. Francke [France] ; R. Sigal [France] ; P. Martinat [France] ; J. P. Pruvo [France] | Anatomie sérielle et IRM des noyaux de la base et du thalamus |
| 000D47 |
A. Parent [Canada] ; F. Cicchetti [Canada] | Anatomie et physiopathologie des ganglions de la base |
| 000D48 |
M. Guttman [Canada] ; J. Burkholder [États-Unis] ; S. J. Kish [Canada] ; D. Hussey [États-Unis] ; A. Wilson [États-Unis] ; J. Dasilva [États-Unis] ; S. Houle [États-Unis] | [11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease : Implications for the symptomatic threshold |
| 000D49 |
F. J. G. Vingerhoets [Canada] ; M. Schulzer [Canada] ; D. B. Calne [Canada] ; B. J. Snow [Canada] | Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? |
| 000D50 |
A. H. Rajput [Canada] ; W. Martin [Canada] ; M.-H. Saint-Hilaire [États-Unis] ; E. Dorflinger [États-Unis] ; S. Pedder [États-Unis] | Tolcapone improves motor function in parkinsonian patients with the "wearing-off" phenomenon: A double-blind, placebo-controlled, multicenter trial |
| 000D53 |
I. H. Richard [États-Unis] ; R. Kurlan [États-Unis] ; C. Tanner [États-Unis] ; S. Factor [États-Unis] ; J. Hubble [États-Unis] ; O. Suchowersky [Canada] ; C. Waters [États-Unis] | Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease |
| 000D54 |
R. Edwards [Canada] ; A. Beuter [Canada] | Sensitivity and specificity of a portable system measuring postural tremor |
| 000D55 |
J. Doyon [Canada] ; D. Gaudreau [Canada] ; R. Jr Laforce [Canada] ; M. Castonguay [Canada] ; P. J. Bedard [Canada] ; F. Bedard [Canada] ; J.-P. Bouchard [Canada] | Role of the striatum, cerebellum, and frontal lobes in the learning of a visuomotor sequence |
| 000D56 |
D. Giaschi [Canada] ; A. Lang [Canada] ; D. Rean [Canada] | Reversible dissociation of sensitivity to dynamic stimuli in Parkinson's disease : is magnocellular function essential to reading motion-defined letters? |
| 000D57 |
N. Paquet [Canada] ; C. W. Y. Hui-Chan [Canada] | Responses to dynamic head-and-body tilts are enhanced in Parkinson's disease |
| 000D59 |
R. Levy [France] ; L.-N. Hazrati [Canada] ; M.-T. Herrero [France, Espagne] ; M. Vila [France] ; O.-K. Hassani [France] ; M. Mouroux [France] ; M. Ruberg [France] ; H. Asensi [Espagne] ; Yves Agid [France] ; J. Feger [France] ; J. A. Obeso [Espagne] ; A. Parent [Canada] ; E. C. Hirsch [France] | Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states |
| 000D60 |
C.-T. Lai [Canada] ; P. H. Yu [Canada] | R(-)-deprenyl potentiates dopamine induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells |
| 000D63 |
A. E. Lang [Canada] ; A. M. Lozano [Canada] ; E. Montgomery [États-Unis] ; J. Duff [Canada] ; R. Tasker [Canada] ; W. Hutchinson [Canada] | Posteroventral medial pallidotomy in advanced Parkinson's disease |
| 000D64 |
S. Rohatagi [États-Unis] ; J. S. Barrett [États-Unis] ; K. E. Dewitt [États-Unis] ; D. Lessard [Canada] ; R. J. Morales [États-Unis] | Pharmacokinetic evaluation of a selegiline pulsatile oral delivery system |
| 000D65 |
A. Strafella [Canada] ; P. Ashby ; A. Lozano ; A. E. Lang | Pallidotomy increases cortical inhibition in Parkinson's disease |
| 000D70 |
K. Markopoulou [États-Unis] ; K. W. Larsen [États-Unis] ; E. K. Wszolek [États-Unis] ; M. A. Denson [États-Unis] ; A. E. Lang [Canada] ; R. F. Pfeiffer [États-Unis] ; Z. K. Wszolek [États-Unis] | Olfactory dysfunction in familial parkinsonism |
| 000D71 |
J. S. Bains [Canada] ; C. A. Shaw [Canada] | Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death |
| 000D73 |
V. Mehta [Canada] ; J. Spears [Canada] ; I. Mendez [Canada] | Neural transplantation in Parkinson's disease |
| 000D74 |
A. M. Lozano [Canada] ; A. E. Lang [Canada] ; W. D. Hutchison [Canada] ; J. O. Dostrovsky [Canada] | Microelectrode recording-guided posteroventral pallidotomy in patients with Parkinson's disease |
| 000D75 |
A. E. Lang [Canada] ; A. Lozano [Canada] ; J. Duff [Canada] ; R. Tasker [Canada] ; J. Miyasaki ; N. Galvez-Jimenez ; W. Hutchison ; J. Dostrovsky | Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration |
| 000D76 |
A. Prochazka [Canada] ; D. J. Bennett [Canada] ; M. J. Stephens [Canada] ; S. K. Patrick [Canada] ; R. Sears-Duru [Canada] ; T. Roberts [Canada] ; J. H. Jhamandas [Canada] | Measurement of rigidity in Parkinson's disease |
| 000D80 |
W. D. Hutchison [Canada] ; A. M. Lozano [Canada] ; R. R. Tasker [Canada] ; A. E. Lang [Canada] ; J. O. Dostrovsky [Canada] | Identification and characterization of neurons with tremor-frequency activity in human globus pallidus |
| 000D82 |
P. L. Mcgeer [Canada] ; C. Schwab [Canada] ; E. G. Mcgeer [Canada] ; R. L. Haddock ; J. C. Steele | Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam |
| 000D83 |
A. Kishore [Canada] ; I. M. Turnbull [Canada] ; B. J. Snow [Canada] ; R. De La Fuente-Fernandez [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; D. B. Calne [Canada] | Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease: Six-month follow-up with additional 1-year observations |
| 000D86 |
W. D. Hutchison [Canada] ; R. Levy [Canada] ; J. O. Dostrovsky [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] | Effects of apomorphine on globus pallidus neurons in parkinsonian patients |
| 000D88 |
C. Schwab [Canada] ; J. C. Steele ; P. L. Mcgeer [Canada] | Dystrophic neurites are associated with early stage extracellular neurofibrillary tangles in the parkinsonism-dementia complex of Guam |
| 000D89 |
M. Novak [Hongrie, Canada] ; C. M. Shapiro [Canada] | Drug-induced sleep disturbances : Focus on nonpsychotropic medications |
| 000D90 |
M. Guttman [Canada] | Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease |
| 000D95 |
A. H. Rajput [Canada] ; M. E. Fenton [Canada] ; D. George [Canada] ; A. Rajput [États-Unis] ; W. Wilson [Canada] ; L. Mcculloch [Canada] | Concordance of common movement disorders among familial cases |
| 000D99 |
C. Schwab [Canada] ; J. C. Steele [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Amyloid P immunoreactivity precedes C4d deposition on extracellular neurofibrillary tangles |
| 000E01 |
K. Rabheru [Canada] ; E. Persad [Canada] | A review of continuation and maintenance electroconvulsive therapy |
| 000E04 |
J. Guridi [Espagne] ; A. M. Lozano [Canada] ; J. G. Martin-Rodriguez ; L. D. Lunsford ; P. J. Kelly ; K. J. Burchiel ; R. J. Maciunas ; B. Blumenkopf ; L. V. Laitinen | A brief history of pallidotomy. Commentaries |
| 000E05 |
R. J. Uitti [Canada] ; H. Shinotoh [Canada] ; M. Hayward [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada] | "Familial Parkinson's disease": A case-control study of families |
| 000E06 |
| |
| 000E07 |
MANOHAR LAL THAKUR [Canada] ; UMA SHANKAR SRIVASTAVA [Canada] | Vitamin-E metabolism and its application |
| 000E11 |
P. J. Blanchet [Canada] ; P. Allard [Canada] ; L. Gregoire [Canada] ; F. Tardif [Canada] ; P. J. Bedard [Canada] | Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients |
| 000E12 |
F. J. G. Vingerhoets [Canada] ; M. Schulzer ; T. J. Ruth ; J. E. Holden ; B. J. Snow | Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-dopa PET in Parkinson's disease |
| 000E13 |
P. Sandor [Canada] ; A. E. Lang [Canada] ; S. Singal [Canada] ; C. Augus [Canada] | Remoxipride in the treatment of levodopa-induced psychosis |
| 000E14 |
N. Galvez-Jimenez [Canada] ; A. E. Lang [Canada] | Perioperative problems in Parkinson's disease and their management : Apomorphine with rectal domperidone |
| 000E15 |
C. Schwab [Canada] ; J. C. Steele ; P. L. Mcgeer [Canada] | Neurofibrillary tangles of Guam parkinson-dementia are associted with reactive microglia and complement proteins |
| 000E16 |
W. G. Tatton [Canada] ; R. M. E. Chalmers-Redman [Canada] | Modulation of gene expression rather than monoamine oxidase inhibition : (-)-Deprenyl-related compounds in controlling neurodegeneration |
| 000E17 |
L. Wahl [Canada] ; C. Nahmias [Canada] | Modeling of fluorine-18-6-fluoro-L-Dopa in humans |
| 000E18 |
O. Yasuhara [Canada] ; C. Schwab [Canada] ; A. Matsuo [Canada] ; S. U. Kim ; J. C. Steele ; I. Akiguchi ; J. Kimura ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Midkine-like immunoreactivity in extracellular neurofibrillary tangles in brains of patients with parkinsonism-dementia complex of Guam |
| 000E20 |
C. L. Barclay [Canada] ; J. Duff ; P. Sandor ; A. E. Lang | Limited usefulness of electroconvulsive therapy in progressive supranuclear palsy |
| 000E21 |
SANJAY KALRA [Canada] ; C. Bergeron [Canada] ; A. E. Lang [Canada] | Lewy body disease and dementia : A review |
| 000E24 |
D. Charbonneau [Canada] ; R. J. Riopelle [Canada] ; R. J. Beninger [Canada] | Impaired incentive learning in treated Parkinson's disease |
| 000E27 |
F. Q. Ye [Canada] ; W. R. M. Martin ; P. S. Allen [Canada] | Estimation of brain iron in vivo by means of the interecho time dependence of image contrast |
| 000E30 |
T. Roberts [Canada] ; U. De Boni ; M. V. Sefton [Canada] | Dopamine secretion by PC12 cells microencapsulated in a hydroxyethyl methacrylate-methyl methacrylate copolymer |
| 000E32 |
C. Schwab [Canada] ; J. C. Steele ; H. Akiyama [Japon] ; P. L. Mcgeer [Canada] | Distinct distribution of apolipoprotein E and β-amyloid immunoreactivity in the hippocampus of Parkinson dementia complex of Guam |
| 000E33 |
J. M. Wilson [Canada] ; A. I. Levey [États-Unis] ; A. Rajput [Canada] ; L. Ang [Canada] ; M. Guttman [Canada] ; K. Shannak [Canada] ; H. B. Niznik [Canada] ; O. Hornykiewicz [Canada, Autriche] ; C. Pifl [Autriche] ; S. J. Kish [Canada] | Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease |
| 000E35 |
C. Bergeron [Canada] ; C. Petrunka ; L. Weyer | Copper/zinc superoxide dismutase expression in the human central nervous system : correlation with selective neuronal vulnerability |
| 000E37 |
L. D. Morrison [Canada] ; D. D. Smith [Canada] ; S. J. Kish [Canada] | Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease |
| 000E38 |
M. J. R. Lamothe [Canada] ; G. Stroink [Canada] ; M. J. Gardner | Body surface potential mapping of a patient with Wolff-Parkinson-White syndrome with two accessory pathways and two atrial pacemaker complexes |
| 000E39 |
F. Q. Ye [Canada] ; P. S. Allen [Canada] ; W. R. W. Martin | Basal ganglia iron content in Parkinson's disease measured with magnetic resonance |
| 000E42 |
B. J. Knowlton [États-Unis] ; J. A. Mangels [Canada, États-Unis] ; L. R. Squire [États-Unis] | A neostriatal habit learning system in humans |
| 000E44 |
M.-A. Bedard [Canada] ; M. Panisset | Neurochimie des troubles cognitifs dans la maladie de Parkinson |
| 000E45 |
L. J. Easdown [Canada] ; M. J. Tessler ; J. Minuk | Upper airway involvement in Parkinson's disease resulting in postoperative respiratory failure |
| 000E49 |
XIAO-HUI ZHONG [Canada] ; J. W. Haycock ; K. Shannak [Canada] ; Y. Robitaille ; J. Fratkin ; A. H. Koeppen ; O. Hornykiewicz [Canada] ; S. J. Kish [Canada] | Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy |
| 000E50 |
A. E. Lang [Canada] ; P. Sandor ; J. Duff [Canada] | Remoxipride in Parkinson's disease : differential response in patients with dyskinesias fluctuations versus psychosis |
| 000E51 |
C. Schwab [Canada] ; J. C. Steele ; H. Akiyama ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Relationship of amyloid β/A4 protein to the neurofibrillary tangles in Guamanian parkinsonism-dementia |
| 000E53 |
M. D. Sharpe [Canada] ; W. B. Dobkowski ; J. M. Murkin ; G. Klein ; R. Yee | Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia |
| 000E54 |
D. V. Exner [Canada] ; T. Muzyka ; A. M. Gillis | Proarrhythmia in patients with the Wolff-Parkinson-White syndrome after standard doses of intravenous adenosine |
| 000E55 |
R. G. Lee [Canada] ; I. Tonolli [France] ; F. Viallet [France] ; R. Aurenty [France] ; J. Massion [France] | Preparatory postural adjustments in Parkinsonian patients with postural instability |
| 000E57 |
C. S. Lee [Canada] ; M. Schulzer ; E. Mak ; J. P. Hammerstad ; S. Calne ; D. B. Calne | Patterns of asymmetry do not change over the course of idiopathic parkinsonism : implications for pathogenesis |
| 000E59 |
E. Mohr [Canada] ; T. Mendis ; J. D. Grimes | Late cognitive changes in Parkinson's disease with an emphasis on dementia |
| 000E63 |
A. M. W. Penn [Canada] ; T. Roberts [Canada] ; J. Hodder [Canada] ; P. S. Allen ; G. Zhu ; W. R. W. Martin [Canada] | Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle |
| 000E64 |
S. Chaturvedi [Canada] ; T. Stbye ; A. J. Stoessl [Canada] ; H. Merskey ; V. Hachinski [Canada] | Environmental exposures in elderly Canadians with Parkinson's disease |
| 000E68 |
A. M. Lozano [Canada] ; A. E. Lang ; N. Galvez-Jimenez ; J. Miyasaki ; J. Duff ; W. D. Hutchinson ; J. O. Dostrovsky | Effect of GPi pallidotomy on motor function in Parkinson's disease |
| 000E70 |
P. Chagnon [Canada] ; C. Betard ; Y. Robitaille ; A. Cholette ; D. Gauvreau | Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases |
| 000E71 |
E. Mohr [Canada] ; P. Brouwers ; J. J. Claus ; S. E. Purdon [Canada] ; M. Gagnon [Canada] ; T. N. Chase | Differential classification of dementia |
| 000E72 |
P. J. Bedard [Canada] | D-1 receptor in neurology and psychiatry : an overview : The role of D-1 dopamine receptors in neurology and psychiatry |
| 000E74 |
S. Cohen [Canada] ; M. Freedman | Cognitive and behavioral changes in the Parkinson-plus syndromes |
| 000E75 |
O. Suchowersky [Canada] ; S. Furtado ; G. Rohs | Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease |
| 000E76 |
J. A. Saint-Cyr [Canada] ; A. E. Taylor ; K. Nicholson | Behavior and the basal ganglia |
| 000E77 |
M.-G. Martinoli [Canada] ; J. Q. Trojanowski ; M. L. Schmidt ; S. E. Arnold ; T. M. Fujiwara ; V. M.-Y. Lee ; H. Hurtig ; J.-P. Julien [Canada] ; C. Clark | Association of apolipoprotein ε4 allele and neuropathologic findings in patients with dementia |
| 000E78 |
J. S. Parboosingh [Canada] ; M. Rousseau [Canada] ; F. Rogan ; Z. Amit ; H. Chertkow ; W. G. Johnson ; F. Manganaro ; H. N. Schipper ; T. J. Curran ; J. Stoessl ; G. A. Rouleau [Canada] | Absence of mutations in superoxide dismutase and catalase genes in patients with Parkinson's disease |
| 000E79 |
C. Nahmias [Canada] ; L. Wahl ; R. Chirakal ; G. Firnau ; E. S. Garnett | A probe for intracerebral aromatic amino-acid decarboxylase activity : distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain |
| 000E80 |
R. Kanthan [Canada] ; A. Shuaib ; G. Goplen ; H. Miyashita | A new method of in-vivo microdialysis of the human brain |
| 000E82 |
| |
| 000E84 |
G. L. Trick [Canada] ; B. Kaskie ; S. B. Steinman | Visual impairment in Parkinson's disease : deficits in orientation and motion discrimination |
| 000E85 |
M. C. Tierney [Canada] ; A. Nores ; W. G. Snow ; R. H. Fisher ; M. L. Zorzitto ; D. W. Reid | Use of the Rey Auditory Verbal Learning Test in differentiating normal aging from Alzheimer's and Parkinson's dementia |
| 000E86 |
A. Beuter [Canada] ; A. De Geoffroy [Canada] ; P. Cordo | The measurement of tremor using simple laser systems |
| 000E87 |
M. D. Sharpe [Canada] ; W. B. Dobkowski ; J. M. Murkin ; G. Klein ; G. Guiraudon ; R. Yee | The electrophysiologic effects of volatile anesthetics and sufentanil on the normal atrioventricular conduction system and accessory pathways in Wolff-Parkinson-White syndrome |
| 000E89 |
D. A. Figlewicz [Canada] ; R. M. Garruto ; A. Krizus [Canada] ; R. Yanagihara ; G. A. Rouleau [Canada] | The Cu/Zn superoxide dismutase gene in ALS and Parkinsonism-dementia of Guam |
| 000E91 |
J. P. Hammerstad [Canada] ; K. Elliott ; E. Mak ; M. Schulzer ; S. Calne ; D. B. Calne | Tendon jerks in Parkinson's disease |
| 000E92 |
T. Mendis [Canada] ; E. Mohr [Canada] ; A. George ; I. N. Rusk [Canada] ; P. Gray ; J. D. Grimes | Symptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride |
| 000E94 |
I. Tooyama [Canada] ; E. G. Mcgeer [Canada] ; T. Kawamata [Canada] ; H. Kimura ; P. L. Mcgeer [Canada] | Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrasts with loss in Parkinson's disease |
| 000E95 |
FU-LIN WANG [Canada] ; K. M. Semchuk ; E. J. Love | Reliability of environmental and occupational exposure data provided by surrogate respondents in a case-control study of Parkinson's disease |
| 000E96 |
FU-LIN WANG [Canada] ; K. M. Semchuk ; E. J. Love | Reliability of environmental and occupational exposure data provided by surrogate respondents in a case-control study of Parkinson's disease |
| 000E97 |
R. K. Mosewich [Canada] ; A. H. Rajput [Canada] ; A. Shuaib [Canada] ; B. Rozdilsky ; L. Ang | Pulmonary embolism: an under-recognized yet frequent cause of death in Parkinsonism |
| 000E99 |
F. J. G. Vingerhoets [Canada] ; B. J. Snow [Canada] ; J. W. Tetrud ; J. W. Langston ; M. Schulzer [Canada] ; D. B. Calne [Canada] | Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions |
| 000F01 |
R. J. Uitti [Canada] ; B. J. Snow [Canada] ; H. Shinotoh [Canada] ; F. J. G. Vingerhoets [Canada] ; M. Hayward [Canada] ; S. Hashimoto ; J. Richmond ; S. P. Markey ; C. J. Markey ; D. B. Calne [Canada] | Parkinsonism induced by solvent abuse |
| 000F02 |
G. M. Guiraudon [Canada] ; C. M. Guiraudon [Canada] ; G. J. Klein [Canada] ; R. Yee [Canada] ; R. K. Thakur [Canada] | Operation for the Wolff-Parkinson-White syndrome in the catheter ablation era |
| 000F03 |
K. Shannak [Canada] ; A. Rajput ; B. Rozdilsky ; S. Kish [Canada] ; J. Gilbert ; O. Hornykiewicz [Canada] | Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus : observations in Parkinson's disease and normal subjects |
| 000F04 |
D. Mergler [Canada] ; G. Huel [Canada] ; R. Bowler ; A. Iregren [Canada] ; S. Belanger [Canada] ; M. Baldwin ; R. Tardif [Canada] ; A. Smargiassi [Canada] ; L. Martin | Nervous system dysfunction among workers with long-term exposure to manganese |
| 000F05 |
D. B. Calne [Canada] ; N.-S. Chu ; C.-C. Huang ; C.-S. Lu ; W. Olanow | Manganism and idiopathic parkinsonism : similarities and differences |
| 000F06 |
F. J. G. Vingerhoets [Canada] ; B. J. Snow ; C. S. Lee ; M. Schulzer ; E. Mak ; D. B. Calne | Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic Parkinsonism |
| 000F07 |
H. Cohen [Canada] ; S. Bouchard ; P. Scherzer ; H. Whitaker | Language and verbal reasoning in Parkinson's disease |
| 000F09 |
O. Yasuhara [Canada] ; T. Kawamata ; Y. Aimi ; E. G. Mcgeer ; P. L. Mcgeer | Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases |
| 000F11 |
R. K. Thakur [Canada] ; G. J. Klein ; R. Yee ; M. Zardini | Embolic complications after radiofrequency catheter ablation |
| 000F12 |
A. H. Rajput [Canada] ; W. R. G. Gibb ; X. H. Zhong ; K. S. Shannak ; S. Kish ; L. G. Chang ; O. Hornykiewicz | Dopa-responsive dystonia : pathological and biochemical observations in a case |
| 000F13 |
W. D. Hutchison [Canada] ; A. M. Lozano ; K. D. Davis [Canada] ; J. A. Saint-Cyr ; A. E. Lang ; J. O. Dostrovsky | Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients |
| 000F14 |
A. Beuter [Canada] ; D. Mergler [Canada] ; A. De Geoffroy [Canada] ; L. Carriere [Canada] ; S. Belanger [Canada] ; L. Varghese [Canada] ; J. Sreekumar [Canada] ; S. Gauthier | Diadochokinesimetry : a study of patients with Parkinson's disease and manganese exposed workers |
| 000F15 |
M. Huberman [Canada] ; M. Moscovitch ; M. Freedman [Canada] | Comparison of patients with Alzheimer's and Parkinson's disease on different explicit and implicit tests of memory |
| 000F18 |
C. Hertzman [Canada] ; M. Wiens ; B. Snow ; S. Kelly ; D. Calne | A case-control study of Parkinson's disease in a horticultural region of British Columbia |
| 000F19 |
D. B. Calne [Canada] | Treatment of Parkinson's disease |
| 000F21 |
S. Weissenborn [Canada] | The effect of using a two-step verbal cue to a visual target above eye level on the Parkinsonian gait : a case study |
| 000F25 |
R. Lemery [Canada] ; M. Talajic ; D. Roy ; L. Lavoie ; B. Coutu ; J. T. Y. Hii ; D. Radzik ; E. Lavallee ; R. Cartier | Results of a comparative study of low energy direct current with radiofrequency ablation in patients with the Wolff-Parkinson-White syndrome |
| 000F26 |
M. S. Pollanen [Canada] ; D. W. Dickson ; C. Bergeron | Pathology and biology of the Lewy body |
| 000F27 |
R. J. Uitti [Canada] ; D. B. Calne | Pathogenesis of idiopathic parkinsonism |
| 000F29 |
M. Dubuc [Canada] ; R. Nadeau [Canada] ; G. Tremblay ; T. Kus ; F. Molin [Canada] ; P. Savard | Pace mapping using body surface potential maps to guide catheter ablation of accessory pathways in patients with Wolff-Parkinson-White syndrome |
| 000F33 |
D. S. Borrett [Canada] ; T. H. Yeap ; H. C. Kwan | Neural networks and Parkinson's disease |
| 000F34 |
E. A. Roy [Canada] ; J. Saint-Cyr ; A. Taylor ; A. Lang | Movement sequencing disorders in Parkinson's disease |
| 000F35 |
J. C. Chen [Canada] ; P. A. Hardy ; W. Kucharczyk [Canada] ; M. Clauberg ; J. G. Joshi ; A. Vourlas [Canada] ; MADHU DHAR ; R. M. Henkelman | MR of human postmortem brain tissue : correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease |
| 000F38 |
M. Wathen [Canada] ; A. Natale ; K. Wolfe ; R. Yee ; G. Klein | Initiation of atrial fibrillation in the Wolff-Parkinson-White syndrome : the importance of the accessory pathway |
| 000F39 |
B. J. Snow [Canada] ; I. Tooyama ; E. G. Mcgeer [Canada] ; T. Yamada ; D. B. Calne [Canada] ; H. Takahashi [Canada] ; H. Kimura | Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels |
| 000F40 |
A. Beuter [Canada] ; J. Belair ; C. Labrie | Feedback and delays in neurological diseases: a modeling study using dynamical systems |
| 000F41 |
H. W. Stites [Canada] ; R. K. Thakur ; R. Yee ; G. J. Klein | Evaluation of an abbreviated protocol for catheter ablation of left free wall accessory pathways |
| 000F42 |
A. H. Rajput [Canada] | Environmental causation of Parkinson's disease |
| 000F51 |
R. Quirion [Canada] | Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release |
| 000F52 |
A. P. Sen [Canada] ; P. Boksa ; R. Quirion | Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases |
| 000F53 |
D. L. Jones [Canada] ; G. J. Klein ; G. M. Guiraudon ; R. Yee | Biphasic versus sequential pulse defibrillation : a direct comparison in humans |
| 000F54 |
K. Mizukawa [Canada] ; E. G. Mcgeer ; P. L. Mcgeer | Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, alzheimer disease, and neurologically normal controls |
| 000F58 |
A. J. Flint [Canada] ; S. E. Black ; I. Campbell-Taylor ; G. F. Gailey ; C. Levinton | Abnormal speech articulation, psychomotor retardation, and subcortical dysfunction in major depression |
| 000F61 |
| 3 rd Canadian conference on neurodegenerative diseases, L'Estérel PQ, April 4-6, 1991 |
| 000F63 |
A. Beuter [Canada] ; L. Carriere ; B. Mcfayden ; S. Gauthier | The organization of stepping in patients with Parkinson's disease : bradykinesia or discoordination ? |
| 000F65 |
D. B. Calne [Canada] | The free radical hypothesis in idiopathic Parkinsonism : evidence against it |
| 000F68 |
M. Schulzer [Canada] ; E. Mark ; D. B. Calne | The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic |
| 000F72 |
R. Lemery [Canada] ; M. Talajic ; D. Roy ; B. Coutu ; L. Lavoie ; E. Lavalle ; R. Cartier | Success, safety, and late electrophysiological outcome of low-energy direct-current ablation in patients with the Wolff-Parkinson-White syndrome |
| 000F73 |
R. Chen [Canada] ; P. Ashby ; A. E. Lang | Stimulus-sensitive myoclonus in akinetic-rigid syndromes |
| 000F74 |
J. Kalra [Canada] ; A. H. Rajput ; S. V. Mantha ; K. Prasad | Serum antioxidant enzyme activity in Parkinson's disease |
| 000F77 |
G. L.-Y. Chan [Canada] ; K. Scott Morrison ; J. E. Holden ; T. J. Ruth | Plasma L-[18F]6-Fluorodopa input function : a simplified method |
| 000F80 |
K. M. Semchuk [Canada] ; E. J. Love ; R. G. Lee | Parkinson's disease and exposure to agricultural work and pesticide chemicals |
| 000F81 |
J. Kalra [Canada] ; A. H. Rajput ; S. V. Mantha ; A. K. Chaudhary ; KAILASH PRASAD | Oxygen free radical producing activity of polymorphonuclear leukocytes in patients with Parkinson's disease |
| 000F82 |
E. Mohr [Canada] ; U. M. Mann ; R. S. Miletich ; M. Sampson ; T. E. Godberg ; J. D. Grimes ; T. N. Chase | Neuropsychological and glucose metabolic profiles in asymmetric Parkinson's disease |
| 000F83 |
T. Yamada [Canada] ; P. L. Mcgeer ; E. G. Mcgeer | Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins |
| 000F88 |
E. Pourcher [Canada] ; B. Gomez-Mancilla ; P. J. Bedard | Ethosuximide and tremor in Parkinson's disease : a pilot study |
| 000F90 |
S. Pare [Canada] ; S. I. Barr ; S. E. Ross | Effect of daytime protein restriction on nutrient intakes of free-living Parkinson's disease patients |
| 000F93 |
M. Guttman [Canada] | Dopamine receptors in Parkinson's disease |
| 000F94 |
M. S. Pollanen [Canada] ; C. Bergeron ; L. Weyer | Detergent-insoluble cortical lewy body fibrils share epitopes with neurofilament and τ |
| 000F95 |
J. L. Cummings [Canada] | Depression and Parkinson's disease : a review |
| 000F98 |
D. B. Calne [Canada] ; B. J. Snow ; C. Lee | Criteria for diagnosing Parkinson's disease |
| 000F99 |
I. Aubert [Canada] ; D. M. Araujo ; D. Cecyre ; Y. Robitaille ; S. Gauthier ; R. Quirion | Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases |
| 001001 |
B. Lach [Canada] ; D. Grimes ; B. Benoit ; A. Minkiewicz-Janda | Caudate nucleus pathology in Parkinson's disease : ultrastructural and biochemical findings in biopsy material |
| 001002 |
S. G. Adams [Canada] ; A. E. Lang | Can the Lombard effect be used to improve low voice intensity in Parkinson's disease? |
| 001004 |
E. G. Mcgeer [Canada] ; E. A. Singh | Angiotensin-converting enzyme in cortisal tissue in Alzheimer's and some other neurological diseases |
| 001007 |
S. J. Kish [Canada] ; K. Shannak ; A. Rajput ; J. H. N. Deck ; O. Hornykiewicz | Aging produces a specific pattern of striatal dopamine loss : implications for the etiology of idopathic Parkinson's disease |
| 001008 |
A. J. Flint [Canada] ; S. E. Black ; I. Campbell-Taylor ; G. F. Gailey ; C. Levinton | Acoustic analysis in the differentiation of Parkinson's disease and major depression |
| 001010 |
M. Cordes [Canada] ; B. J. Snow ; H. Takahashi ; P. Schofield ; S. Cooper ; V. Sossi ; S. Morrison ; D. B. Calne | L-18F-DOPA-PET bei Parkinson-Plus-Syndromen zum Nachweis einer gestörten präsynaptischen dopaminergen Funktion |
| 001011 |
S. Bagley [Canada] ; B. Kelly ; N. Tunnicliffe ; G. I. Turnbull ; J. M. Walker | The effect of visual cues on the gait of independently mobile Parkinson's disease patients |
| 001014 |
WEE SION TEO ; G. J. Klein ; R. Yee ; J. W. Leitch ; C. J. Murdock | Significance of minimal preexcitation in Wolff-Parkinson-White syndrome |
| 001016 |
R. A. Leather [Canada] ; J. W. Leitch ; G. J. Klein ; G. M. Guiraudon ; R. Yee ; YOU HO KIM | Radiofrequency catheter ablation of accessory pathways : a learning experience |
| 001017 |
M. H. Bhatt ; B. J. Snow ; W. R. Wayne Martin ; B. D. Pate ; D. B. Calne | Positron emission tomography suggests that the rate of progression of idiopthic parkinsonism is slow |
| 001018 |
K. M. Semchuk [Canada] ; E. J. Love ; R. G. Lee | Parkinson's disease and exposure to rural environmental factors : a population based case-control study |
| 001019 |
J. A. Jesberger ; J. S. Richardson | Oxygen free radicals and brain dysfunction |
| 001020 |
A. H. Rajput [Canada] ; B. Rozdilsky ; L. Ang | Occurrence of resting tremor in Parkinson's disease |
| 001021 |
D. B. Calne [Canada] | Neurotoxins and degeneration in the central nervous system |
| 001023 |
WEE SIONG TEO ; G. J. Klein ; G. M. Guiraudon ; R. Yee ; J. W. Leitch ; D. Mclellan ; R. A. Leather ; YOU HO KIM | Multiple accessory pathways in the Wolff-Parkinson-White syndrome as a risk factor for ventricular fibrillation |
| 001024 |
J. C. S. Furtado [Canada] ; M. F. Mazurek | MPTP-induced neurotoxicity and the quest for a preventative therapy for Parkinson's disease |
| 001027 |
C. J. Murdock [Canada] ; J. W. Leitch ; G. J. Klein ; G. M. Guiraudon ; R. Yee ; WEES SIONG TEO | Epicardial mapping in patients with "nodoventricular" accessory pathways |
| 001028 |
J. Poirier [Canada] ; S. Kogan ; S. Gauthier | Environment, genetics and idiopathic Parkinson's disease |
| 001032 |
O. S. Kofman [Canada] | Deprenyl : protective vs. symptomatic effect |
| 001033 |
D. B. Calne ; M. J. Zigmond | Compensatory mechanisms in degenerative neurologic diseases : insights from Parkinsonism |
| 001034 |
A. H. Rajput [Canada] ; B. Rozdilsky ; L. Ang ; A. Rajput | Clinicopathologic observations in essential tremor : report of six cases |
| 001035 |
C. Giorgi ; R. Nadeau ; P. Savard ; M. Shenasa ; P. L. Page ; R. Cardinal | Body surface potential mapping in the evaluation of coexisting old myocardial infarction and ventricular preexcitation |
| 001036 |
C. Giorgi ; R. Nadeau ; P. Savard ; M. Shenasa ; P. L. Page ; R. Cardinal | Body surface isopotential mapping of the entire QRST complex in the Wolff-Parkinson-White syndrome. Correlation with the location of the accessory pathway |
| 001038 |
E. Keller [Canada] ; P. Vigneux ; M. Laframboise | Acoustic analysis of neurologically impaired speech |
| 001039 |
A. H. Rajput [Canada] ; B. Rozdilsky ; A. Rajput | Accuracy of clinical diagnosis in Parkinsonism―A prospective study |
| 001041 |
J. Zayed ; P. Andre ; J. C. Panisset ; S. Ducic ; G. Campanella ; M. Roy ; G. Kennedy ; C. Delisle | Contamination environnementale par les métaux et maladie de Parkinson |
| 001042 |
A. J. Lewis ; M. J. Gawel | diffuse lewy body disease with dementia and oculomotor dysfunction |
| 001043 |
S. J. Kish ; L. M. Distefano ; S. Dozic ; Y. Robitaille ; A. Rajput ; J. H. N. Deck ; O. Hornykiewicz | [3H]vesamicol binding in human brain cholinergic deficiency disorders |
| 001044 |
K. A. Boahene ; G. J. Klein ; A. D. Sharma ; R. Yee ; O. Fujimura | Value of a revised procainamide test in the Wolff-Parkinson-White syndrome |
| 001046 |
P. L. Page [Canada] ; L. C. Pelletier ; W. Kaltenbrunner ; E. Vitali ; D. Roy ; R. Nadeau | Surgical treatment of the Wolff-Parkinson-White syndrome : endocardial versus epicardial approach |
| 001047 |
G. M. Guiraudon ; G. J. Klein ; R. Yee ; R. Kaushik ; D. G. Mclellan ; D. M. Cade | Surgical epicardial ablation of left ventricular pathway using sling exposure |
| 001048 |
N. R. C. Campbell ; D. Rankine ; A. E. Goodridge ; B. B. Hasinoff ; M. Kara | Sinemet-ferrous sulphate interaction in patients with Parkinson's disease |
| 001050 |
M. H. Bhatt ; B. J. Snow ; W. R. W. Martin ; S. Cooper ; D. B. Calne | Positron emission tomography in Shy-Drager syndrome |
| 001051 |
B. J. Snow ; R. F. Peppard ; M. Guttman ; J. Okada ; W. Martin ; J. Steele ; A. Eisen ; G. Carr ; B. Schoenberg ; D. Calne | Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in lytico-bodig : the amyotrophic lateral sclerosis-Parkinsonism-dementia complex of guam |
| 001053 |
M. Freedman | Object alternation and orbitofrontal system dysfunction in Alzheimer's and Parkinson's disease |
| 001054 |
D. Pare ; R. Curro'Dossi ; M. Steriade | Neuronal basis of the Parkinsonian resting tremor : a hypothesis and its implications for treatment |
| 001055 |
E. R. Vriezen [Canada] ; M. Moscovitch | Memory for temporal order and conditional associative-learning in patients with Parkinson's disease |
| 001056 |
A. E. Taylor ; J. A. Saint-Cyr ; A. E. Lang | Memory and learning in early Parkinson's disease : evidence for a frontal lobe syndrome |
| 001057 |
C. J. Murdock ; G. J. Klein ; R. Yee ; J. W. Leitch | Management of the patient with the Wolff-Parkinson-White syndrome |
| 001059 |
A. J. Hudson ; G. P. A. Rice | Hipothesis : similitaries of guamanian ALS/PD to post-encephalitic Parkinsonism/ALS : possible viral cause |
| 001060 |
R. Turcotte ; C. Godin ; R. Duchesne ; A. Jodoin | Hip fractures and Parkinson's disease : a clinical review of 94 fractures treated surgically |
| 001061 |
L. W. Svenson | Geographic distribution of deaths due to Parkinson's disease in Canada : 1979-1986 |
| 001062 |
J. Zayed ; S. Ducic ; G. Companella ; J. C. Panisset ; P. Andre ; H. Masson ; M. Roy | Facteurs environnementaux dans l'étiologie de la maladie de Parkinson |
| 001065 |
R. T. Ross | Drug-induced Parkinsonism and other movement disorders |
| 001067 |
P. Seeman ; H. B. Niznik | Dopamine receptors and transporters in Parkinson's disease and schizophrenia |
| 001068 |
T. L. Perry ; J. M. Wright ; K. Berry ; S. Hansen ; T. L. Jr Perry | Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome : clinical, biochemical, and neuropathologic studies of 2 new cases |
| 001069 |
A. Beuter [Canada] ; J. G. Milton ; C. Labrie ; L. Glass ; S. Gauthier | Delayed visual feedback and movement control in Parkinson's disease |
| 001070 |
J. K. C. Tsui ; R. F. Peppard ; K. C. Petruk ; G. Allen ; R. S. Burns ; D. B. Calne | Decreased efficay of levodopa with carbidopa in parkinsonian patients after adrenal-to-caudate implants |
| 001071 |
C. Harnois ; T. Di Paolo | Decreased dopamine in the retinas of patients with Parkinson's disease |
| 001072 |
R. F. Peppard ; W. R. W. Martin ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. Calne | Cortical glucose metabolism in Parkinson's and Alzheimer's disease |
| 001073 |
T. Yamada ; H. Akiyama ; P. L. Mcgeer | Complement-activated oligodendroglia : a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d |
| 001074 |
E. C. Wolters ; T. A. Hurwitz ; E. Mak ; P. Teal ; F. R. Peppard ; R. Remick ; S. Calne ; D. B. Calne | Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis |
| 001075 |
A. E. Lang ; D. E. Riley ; L. Vachon ; X. Lataste | CQA 206-291 in Parkinson's disease : an acute single escalating dosage study |
| 001076 |
M. Zardini ; J. W. Leitch ; G. M. Guiraudon ; G. J. Klein ; R. Yee | Atrioventricular nodal reentry and dual atrioventricular node physiology in patients undergoing accessory pathway ablation |
| 001077 |
A. W. R. Jones ; J. S. Richardson | Alzheimer's disease : clinical and pathological characteristics |
| 001078 |
D. B. Calne | Is «Parkinson's disease» one disease? |
| 001080 |
T. S. Szabo ; G. J. Klein ; A. D. Sharma ; R. Yee ; S. Milstein | Usefulness of isoproterenol during atrial fibrillation in evaluation of asymptomatic Wolff-Parkinson-White pattern |
| 001081 |
VOON WEE YONG ; M. Guttman ; S. U. Kim ; D. B. Calne ; I. Turnbull ; K. Watabe ; R. W. W. Tomlinson | Transplantation of human sympathetic neurons and adrenal chromaffin cells into parkinsonian monkeys: no reversal of clinical symptoms |
| 001082 |
J. K. Tsui ; S. Ross ; K. Poulin ; J. Douglas ; D. Postnikoff ; S. Calne ; W. Woodward ; D. B. Calne | The effect of dietary protein on the efficacy of L-dopa: a double-blind study |
| 001084 |
W. G. Vincken ; C. M. Darauay ; M. G. Cosio | Reversibility of upper airway obstruction after levodopa therapy in Parkinson's disease |
| 001086 |
R. J. Uitti ; A. H. Rajput ; B. Rozdilsky ; M. Bickis ; T. Wollin ; W. K. Yuen | Regional metal concentrations in Parkinson1s disease, other chronic neurological diseases, and control brains |
| 001087 |
E. C. Wolters ; C.-C. Huang ; C. Clark ; R. F. Peppard ; J. Okada ; N.-S. Chu ; M. J. Adam ; T. J. Ruth ; D. Li ; D. B. Calne | Positron emission tomography in manganese intoxication |
| 001089 |
A. H. Rajput ; R. J. Uitti ; S. Sudhakar ; B. Rozdilsky | Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei |
| 001090 |
M. Guttman ; R. S. Burns ; W. R. W. Martin ; R. F. Peppard ; M. J. Adam ; T. J. Ruth ; G. Allen ; R. A. Parker ; N. B. Tulipan ; D. B. Calne | PET studies of Parkinsonian patients treated with autologous adrenal implants |
| 001091 |
H. Teravainen ; J. K. C. Tsui ; E. Mak ; D. B. Calne | Optimal indices for testing parkinsonian rigidity |
| 001092 |
G. J. Klein ; R. Yee ; A. D. Sharma | Longitudinal electrophysiologic assessment of asymtomatic patients with the Wolff-Parkinson-White electrocardiographic pattern |
| 001094 |
D. Riley ; A. E. Lang ; R. D. G. Blair ; A. Birnbaum ; B. Reid | Frozen shoulder and other shoulder disturbances in Parkinson's disease |
| 001095 |
M. Dubuc ; T. Kus ; M. A. Campa ; C. Lambert ; M. Rosengarten ; MOHAMMAD SHENASA | Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome |
| 001100 |
E. C. Wolters ; T. A. Hurwitz ; R. F. Peppard ; D. B. Calne | Clozapine: an antipsychotic agent in Parkinson's disease? |
| 001101 |
G. J. Klein ; E. N. Prystowsky ; R. Yee ; A. D. Sharma ; A. Laupacis | Asymptomatic Wolff-Parkinson-White. Should we intervene? |
| 001102 |
O. Fujimura ; G. J. Klein ; A. D. Sharma ; R. Yee ; T. Szabo | Acute effect of disopyramide on atrial fibrillation in the Wolff-Parkinson-White syndrome |
| 001103 |
T. A. Cox ; J. V. Mcdarby ; L. Lavine ; J. C. Steele ; D. B. Calne | A retinopathy on Guam with high prevalence in Lytico-Bodig |
| 001104 |
J. K. C. Tsui ; E. C. Wolters ; R. F. Peppard ; D. B. Calne | A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease |
| 001105 |
S. J. Kish ; K. Shannak ; O. Hornykiewicz | Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications |
| 001106 |
T. A. Hurwitz ; D. B. Calne ; K. Waterman | Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapy |
| 001107 |
G. M. Guiraudon ; C. M. Guiraudon ; G. J. Klein ; A. D. Sharma ; R. Yee | The coronary sinus diverticulum: a pathologic entity associated with the Wolff-Parkinson-White syndrome |
| 001109 |
G. M. Guiraudon ; G. J. Klein ; A. D. Sharma ; R. Yee ; E. A. Pineda ; D. G. Mclellan ; O. C. Penn ; A. H. Piwnica | Surgical approach to anterior septal accessory pathways in 20 patients with the Wolff-Parkinson-White syndrome |
| 001110 |
F. A. Lenz ; R. R. Tasker ; H. C. Kwan ; S. Schnider ; R. Kwong ; Y. Murayama ; J. O. Dostrovsky ; J. T. Murphy | Single unit analysis of the human ventral thalamic nuclear group: correlation of thalamic "tremor cells" with the 3-6 Hz component of Parkinsonian tremor |
| 001111 |
D. L. Jones ; G. J. Klein ; G. M. Guiraudon ; A. D. Sharma | Sequential pulse defibrillation in humans: orthogonal sequential pulse defibrillation with epicardial electrodes |
| 001113 |
P. L. Mcgeer ; S. Itagaki ; B. E. Boyes ; E. G. Mcgeer | Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains |
| 001114 |
P. L. Mcgeer ; S. Itagaki ; H. Akiyama ; E. G. Mcgeer | Rate of cell death in parkinsonism indicates active neuropathological process |
| 001115 |
J. A. Saint-Cyr ; A. E. Taylor ; A. E. Lang | Procedural learning and neostriatal dysfunction in man |
| 001117 |
D. Riley ; A. E. Lang | Practical application of a low-protein diet for Parkinson's disease |
| 001119 |
R. Nadeau ; A. Ackaoui ; C. Giorgi ; P. Savard ; M. Shenasa ; P. Page | PQRST isoarea maps from patients with the Wolff-Parkinson-White syndrome: an index for global alterations of ventricular repolarization |
| 001120 |
M. W. Rogers ; C. W. Y. Chan | Motor planning is impaired in Parkinson's disease |
| 001121 |
D. B. Calne ; A. J. Lees | Late progression of post encephalitic Parkinson's syndrome |
| 001122 |
A. E. Taylor ; J. A. Saint-Cyr ; A. E. Lang | Idiopathic Parkinson's disease: revised concepts of cognitive and affective status |
| 001123 |
M. N. Hassan ; J. H. Thakar | Dopamine receptors in Parkinson's disease |
| 001124 |
J. J. Gilbert ; S. J. Kish ; LI-JAN CHANG ; C. Morito ; K. Shannak ; O. Hornykiewicz | Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates |
| 001125 |
T. L. Perry ; S. Hansen ; K. Jones | Brain amino acids and glutathione in progressive supranuclear palsy |
| 001127 |
J. P. Hunter ; P. Ashby ; A. E. Lang | Afferent contributing to the exaggerated long latency reflex response to electrical stimulation in Parkinson's disease |
| 001133 |
G. M. Guiraudon ; G. J. Klein ; A. D. Sharma ; R. Yee ; E. A. Pineda | "Atypical" posteroseptal accessory pathway in Wolff-Parkinson-White syndrome |
| 001136 |
R. Nadeau | Wolff-Parkinson-White VCG patterns |
| 001137 |
M. Freedman ; M. Oscar-Berman | Tactile discrimination learning deficits in Alzheimer's and Parkinson's diseases |
| 001138 |
J. A. Sharpe ; W. A. Fletcher ; A. E. Lang ; D. H. Zackon | Smooth pursuit during dose-related on-off fluctuations in Parkinson's disease |
| 001139 |
A. A. F. Sima ; G. Hoag ; B. Rozdilsky | Shy-Drager syndrome: the transitional variant |
| 001140 |
A. D. Sharma ; R. Yee ; G. Guiraudon ; G. J. Klein | Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome |
| 001141 |
M. M. Finkelstein ; G. M. Liss | Selection bias in occupational case-control studies that use death registries to select subjects: a discussion and demonstration |
| 001142 |
A. E. Lang | Restless legs syndrome and Parkinson's disease: insights into pathophysiology |
| 001143 |
C. Rinne ; G. J. Klein ; A. D. Sharma ; R. Yee ; S. Milstein ; M. F. Rattes | Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome |
| 001144 |
A. E. Taylor ; J. A. Saint-Cyr ; A. E. Lang | Parkinson's disease: cognitive changes in relation to treatment response |
| 001145 |
D. Regan ; C. Maxner | Orientation-selective visual loss in patients with Parkinson's disease |
| 001147 |
H. A. Robertson ; G. S. Robertson | Hypothesis. Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action |
| 001148 |
S. Calne ; B. Schoenberg ; W. Martin ; R. J. Uitti ; P. Spencer ; D. B. Calne | Familial Parkinson's disease: possible role of environmental factors |
| 001150 |
J. Poirier ; A. Barbeau | Erythrocyte antioxidant activity in human patients with Parkinson's disease |
| 001151 |
L. Brent Mitchell ; D. G. Wyse ; H. J. Duff | Electropharmacology of sotalol in patients with Wolff-Parkinson-White syndrome |
| 001152 |
MOHAMMAD SHENASA ; M. Fromer ; G. Faugere ; R. Nadeau ; R. A. Leblanc ; C. Lambert ; MOHAMMAD ALI SADR-AMELI | Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome |
| 001155 |
S. Milstein ; G. J. Klein ; M. F. Rattes ; A. D. Sharma ; R. Yee | Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome |
| 001157 |
D. Kimura ; A. Hahn ; H. J. M. Barnett | Attentional and perseverative impairment in two cases of familial fatal Parkinsonism with cortical sparing |
| 001158 |
A. E. Lang ; K. Johnson | Akathisia in idiopathic Parkinson's disease |
| 001159 |
I. Libman ; M. J. Gawel ; R. J. Riopelle ; S. Bouchard | A comparison of bromocriptine (Parlodel®) and levodopa-carbidopa (Sinemet®) for treatment of "De Novö Parkinson's disease patients |
| 001160 |
A. H. Rajput ; K. P. Offord ; C. M. Beard ; L. T. Kurland | A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease |
| 001162 |
| Proceedings/Systems approach in Vision. Workshop, Amsterdam, 26-29 August 1984 |
| 001163 |
W. M. Miles ; R. Yee ; G. J. Klein ; D. P. Zipes ; E. N. Prystowsky | The preexcitation index: an aid in determining the mechanism of supraventricular tachycardia and localizing accessory pathways |
| 001164 |
H. Teravainen ; L. Forgach ; M. Hietanen ; M. Schulzer ; B. Schoenberg ; D. B. Calne | The age of onset of Parkinson's disease: etiological implications |
| 001167 |
C. B. Bozek ; O. Suchowersky ; S. Purves ; S. Calne ; D. B. Calne | Sinemet in Parkinson's disease: efficacy with and without food |
| 001168 |
M. Freedman ; M. Oscar-Berman | Selective delayed response deficits in Parkinson's and Alzheimer's disease |
| 001172 |
J. H. Moss ; D. E. Stewart | Iatrogenic Parkinsonism in Huntington's chorea |
| 001173 |
H. Kamo ; S. U. Kim ; P. L. Mcgeer ; D. H. Shin | Functional recovery in a rat model of Parkinson's disease following transplantation of cultured human sympathetic neurons |
| 001174 |
A. E. Taylor ; J. A. Saint-Cyr ; A. E. Lang | Frontal lobe dysfunction in Parkinson's disease |
| 001175 |
J. Kish ; A. Rajput ; J. Gilbert ; B. Rozdilsky ; L.-J. Chang ; K. Shannak ; O. Hornykiewicz | Elevated γ-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss |
| 001176 |
E. Lau ; K. Waterman ; R. Glover ; M. Schulzer ; D. B. Calne | Effect of antacid on levodopa therapy |
| 001177 |
A. H. Rajput ; R. J. Uitti ; W. Stern ; W. Laverty | Early onset Parkinson's disease in Saskatchewan-environmental considerations for etiology |
| 001178 |
M. Guttman ; P. Seeman ; G. P. Reynolds ; P. Riederer ; K. Jellinger ; W. W. Tourtellotte | Dopamine D2 receptor density remains constant in treated Parkinson's disease |
| 001180 |
C. W. Y. Chan | Could parkinsonian akinesia be attributable to a disturbance in the motor preparatory process? |
| 001183 |
G. M. Guiraudon ; G. J. Klein ; A. D. Sharma ; S. Milstein ; D. G. Mclellan | Closed-heart technique for Wolff-Parkinson-White syndrome: further experience and potential limitations |
| 001186 |
W. R. W. Martin | Positron emission tomography in movement disorders |
| 001187 |
K. S. Polyzoidis ; J. D. Mc Queen ; A. H. Rajput ; D. J. Mac Fadyen | Parkinsonism as a manifestation of brain tumor |
| 001188 |
R. J. Uitti ; A. H. Rajput ; E. M. Ashenhurst ; B. Rozdilsky | Cyanide-induced parkinsonism: a clinicopathologic report |
| 001189 |
C. J. Gibson ; M. Logue ; J. H. Growdon | CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease |
| 001190 |
R. Yee ; G. J. Klein | Atrioventricular nodal reentry in the Wolff-Parkinson-White syndrome |
| 001191 |
A. D. Sharma ; G. J. Klein ; G. M. Guiraudon ; S. Milstein | Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway |
| 001192 |
D. Regan ; D. Neima | Visual fatigue and visual evoked potentials in multiple sclerosis, glaucoma, ocular hypertension and Parkinson's disease |
| 001193 |
T. A. Larsen ; R. Newman ; P. Lewitt ; D. B. Calne | Severity of Parkinsońs disease and the dosage of bromocriptine |
| 001194 |
D. Regan ; D. Neima | Low-contrast letter charts in early diabetic retinopaphy, ocular hypertension, glaucoma, and Parkinson's disease |
| 001195 |
A. H. Rajput ; K. P. Offord ; C. M. Beard ; L. T. Kurland | Epidemiology of Parkinsonism: incidence, classification, and mortality |
| 001197 |
W. G. Tatton ; W. Bedingham ; M. C. Verrier ; R. D. G. Blair | Characteristic alterations in responses to imposed wrist displacements in parkinsonian rigidity and dystonia musculorum deformans |
| 001198 |
J. D. Grimes ; D. B. King ; O. S. Kofman ; P. Molina-Negro ; A. F. Wilson ; S. Bouchard | Bromocriptine in the management of end of dose deterioration in Parkinson's disease |
